<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18368530</article-id>
      <article-id pub-id-type="pmc">2245998</article-id>
      <article-id pub-id-type="publisher-id">9078</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9078-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>P2 receptors in cardiovascular regulation and disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Erlinge</surname>
            <given-names>David</given-names>
          </name>
          <address>
            <phone>+46-46-172597</phone>
            <fax>+46-46-157857</fax>
            <email>david.erlinge@med.lu.se</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Burnstock</surname>
            <given-names>Geoffrey</given-names>
          </name>
          <address>
            <phone>+44-020-78302948</phone>
            <fax>+44-020-78302949</fax>
            <email>g.burnstock@ucl.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Cardiology, Lund University Hospital, 22185 Lund, Sweden </aff>
        <aff id="Aff2"><label>2</label>Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London, NW3 2PF UK </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>20</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>5</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>8</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>The role of ATP as an extracellular signalling molecule is now well established and evidence is accumulating that ATP and other nucleotides (ADP, UTP and UDP) play important roles in cardiovascular physiology and pathophysiology, acting via P2X (ion channel) and P2Y (G protein-coupled) receptors. In this article we consider the dual role of ATP in regulation of vascular tone, released as a cotransmitter from sympathetic nerves or released in the vascular lumen in response to changes in blood flow and hypoxia. Further, purinergic long-term trophic and inflammatory signalling is described in cell proliferation, differentiation, migration and death in angiogenesis, vascular remodelling, restenosis and atherosclerosis. The effects on haemostasis and cardiac regulation is reviewed. The involvement of ATP in vascular diseases such as thrombosis, hypertension and diabetes will also be discussed, as well as various heart conditions. The purinergic system may be of similar importance as the sympathetic and renin-angiotensin-aldosterone systems in cardiovascular regulation and pathophysiology. The extracellular nucleotides and their cardiovascular P2 receptors are now entering the phase of clinical development.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>ATP</kwd>
        <kwd>Cardiovascular</kwd>
        <kwd>Heart</kwd>
        <kwd>Pathophysiology</kwd>
        <kwd>Purine</kwd>
        <kwd>Pyrimidine</kwd>
        <kwd>P2X</kwd>
        <kwd>P2Y</kwd>
        <kwd>Receptor</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Ever since the first proposition of cell surface receptors for nucleotides [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], it has become increasingly clear that, in addition to functioning as an intracellular energy source, the purines and pyrimidines ATP, adenosine diphosphate (ADP), uridine triphosphate (UTP) and uridine diphosphate (UDP) can serve as important extracellular signalling molecules [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>] acting on 13 P2X homo- and heteromultimer ionotropic and 8 P2Y metabotropic receptor subtypes [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). To terminate signalling, ectonucleotidases are present in the circulation and on cell surfaces, rapidly degrading extracellular ATP into ADP, AMP and adenosine [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Evidence is accumulating suggesting an important role for the purinergic system in cardiovascular regulation [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>]. It stimulates vasoconstriction and vasodilatation, growth of vascular smooth muscle cells and endothelial cells, angiogenesis, is involved in vascular remodelling, stimulates platelet aggregation, regulates coagulation, inflammation and several aspects of cardiac function. It is involved in blood pressure regulation, development of myocardial infarction, heart failure and xenograft rejection. The physiological effects of the purinergic signalling system are dependent on the release of extracellular nucleotides, the degradation by ectonucleotides, the type of P2 receptors expressed on the cells, their desensitisation rates and their second messengers. P2 receptors have highly specific organ distributions and they can be rapidly up- or downregulated. The purinergic system may be of similar importance as the sympathetic and renin-angiotensin-aldosterone systems in cardiovascular regulation and pathophysiology. The involvement of purinergic signalling in a variety of different cardiovascular clinical conditions has been addressed to a limited extent previously [<xref ref-type="bibr" rid="CR15">15</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>] and the large number of new discoveries calls for a review to summarise the most important roles of the purinergic system in cardiovascular regulation and disease.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Receptor classification, intracellular signalling, ligands and selective agonists and antagonists</p></caption><table frame="hsides" rules="groups"><thead><tr><th>P2 subtype</th><th>I.c. signalling</th><th>Ligand</th><th>Selective agonist</th><th>Selective antagonist</th><th>Non-selective antagonist</th></tr></thead><tbody><tr><td>P2Y<sub>1</sub></td><td>&#x2191;IP3</td><td>ADP (ATP)</td><td>MRS2365</td><td>MRS 2179, MRS2500</td><td/></tr><tr><td>P2Y<sub>2</sub></td><td>&#x2191;IP3</td><td>UTP = ATP</td><td>MRS2498, UTP&#x3B3;S, INS3717</td><td/><td>Suramin &gt; RB2</td></tr><tr><td>P2Y<sub>4</sub></td><td>&#x2191;IP3</td><td>UTP (=ATP in rodents)</td><td>UTP&#x3B3;S, INS3717</td><td>&#x2013;</td><td>RB2 &gt; Suramin</td></tr><tr><td>P2Y<sub>6</sub></td><td>&#x2191;IP3</td><td>UDP</td><td>MRS2666, MRS2633, UDP&#x3B2;S</td><td>MRS2578</td><td/></tr><tr><td>P2Y<sub>11</sub></td><td>&#x2191;IP3, &#x2191;cAMP</td><td>ATP</td><td>AR-C67085MX, NF546</td><td>NF157</td><td>Suramin &gt; RB2</td></tr><tr><td>P2Y<sub>12</sub></td><td>&#x2193;cAMP</td><td>ADP</td><td>&#x2013;</td><td>Clopidogrel, prasugrel, AZD6140, INS50589, AR-C9931 (cangrelor)</td><td/></tr><tr><td>P2Y<sub>13</sub></td><td>&#x2193;cAMP</td><td>ADP</td><td>&#x2013;</td><td>MRS2211</td><td/></tr><tr><td>P2Y<sub>14</sub></td><td>IP3</td><td>UDP-glucose, UDP-galactose</td><td>UDP-glucose, UDP-galactose</td><td>&#x2013;</td><td/></tr><tr><td>P2X<sub>1</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x3B1;,&#x3B2;-mATP</td><td>NF023, NF449</td><td>TNP-ATP, Ip<sub>5</sub>I</td></tr><tr><td>P2X<sub>2</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x2013;</td><td>NF770</td><td>Suramin, isoPPADS, RB2</td></tr><tr><td>P2X<sub>3</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x3B1;,&#x3B2;-mATP</td><td>A317491, NF110</td><td>Suramin</td></tr><tr><td>P2X<sub>4</sub></td><td>Positive ion channel</td><td>ATP</td><td>Ivermectin potentiates</td><td>&#x2013;</td><td>TNP-ATP</td></tr><tr><td>P2X<sub>5</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x2013;</td><td>&#x2013;</td><td>Suramin, PPADS</td></tr><tr><td>P2X<sub>6</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td></tr><tr><td>P2X<sub>7</sub></td><td>Positive ion channel</td><td>ATP</td><td>&#x2013;</td><td>KN62, KN04, MRS2427</td><td>Coomassie brilliant blue G</td></tr><tr><td>Ectonucleotidase</td><td/><td/><td>Apyrase, human SolCD39</td><td>ARC67156</td><td/></tr></tbody></table></table-wrap></p>
      <p>The research field has grown rapidly since the term P2 receptor was coined [<xref ref-type="bibr" rid="CR2">2</xref>]. In preparation of this review more than 2,700 references on P2 receptors and cardiovascular regulation were found in PubMed. Among the 15 receptor subtypes, one is the target for one of the most widely used medical drugs&#x2014;the platelet inhibitor clopidogrel (Plavix). As will be reviewed here, several of the other 15 receptors are promising drug targets to prevent cardiovascular disease.</p>
    </sec>
    <sec id="Sec2">
      <title>Regulation of vascular tone</title>
      <p>Vasoconstriction produced by ATP released as a cotransmitter with noradrenaline (NA) from perivascular sympathetic nerves was recognised early [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. However, following the seminal discovery of endothelium-dependent vasodilatation by Furchgott in the early 1980s, it was shown that ATP acted on endothelial cells to release endothelial derived relaxing factor [later shown to be largely nitric oxide (NO)] resulting in vasodilatation [<xref ref-type="bibr" rid="CR22">22</xref>] and dual purinergic neural and endothelial control of vascular tone established [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <sec id="Sec3">
        <title>Neuronal regulation of vascular tone</title>
        <p>ATP is, together with NA and neuropeptide Y (NPY), a cotransmitter in sympathetic neurons [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], and sensory-motor nerves during &#x201C;axon reflex&#x201D; activity release ATP to dilate or constrict vessels [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The contribution of ATP to sympathetic contraction varies between vascular beds [<xref ref-type="bibr" rid="CR25">25</xref>]. For example, it may mediate up to 50% of the neurogenic vasoconstriction via P2X<sub>1</sub> receptors as seen in mesenteric arteries [<xref ref-type="bibr" rid="CR29">29</xref>], about 70% in rabbit saphenous arteries and 100% in rabbit jejunal artery, while NA acts as a prejunctional modulator [<xref ref-type="bibr" rid="CR30">30</xref>]. In the renal vasculature both P2X<sub>1</sub> and P2Y<sub>2</sub> receptors are important for neurogenic contraction. P2X<sub>1</sub> receptors mediate contraction in afferent but are absent in the efferent renal arterioles [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. The result is that extracellular nucleotides selectively influence preglomerular resistance without having an effect on postglomerular tone. ATP is also released locally in the kidney in response to increased perfusion pressure, and in P2X<sub>1</sub> receptor knockout mice auto-regulatory responses in kidney afferent arterioles are abolished, indicating an important role in renal glomerular pressure regulation [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>P2 receptor-mediated regulation of the circulation. See text for details. Purines and pyrimidines are released on the luminal side from endothelial cells, platelets and red blood cells (<italic>RBC</italic>) in response to hypoxia, acidosis, adrenaline, shear stress and other stimuli. When the endothelial cell layer is intact, the response is vasodilatation by the endothelial release of nitric oxide (<italic>NO</italic>), endothelium-derived hyperpolarising factor (<italic>EDHF</italic>) and prostaglandins (<italic>Pgl</italic>). When the endothelium is damaged, platelets accumulate, release ATP and ADP and mediate vasoconstriction via P2 receptors on the vascular smooth muscle cell (<italic>VSMC</italic>). On the adventitial side sympathetic and sensory nerves mediate vasoconstriction. Extracellular nucleotides are rapidly degraded by NTPDase1 on endothelium reducing ATP to AMP, followed by conversion to adenosine by CD73 (not shown). In the subendothelium NTPDase2 is present, degrading ATP to ADP, maintaining the platelet activating and contractile effects. <italic>Ado</italic> adenosine, <italic>CGRP</italic> calcitonin gene-related peptide, <italic>SP</italic> substance P</p></caption><graphic position="anchor" xlink:href="11302_2007_9078_Fig1_HTML" id="MO1"/></fig></p>
        <p>Sympathetic nerves express inhibitory P2Y and P1 (A<sub>1</sub>) receptors indicating a P2 receptor-mediated negative feedback loop both directly by ATP and its degradation product adenosine [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Ectonucleotidases are released from sympathetic nerves together with its substrate ATP, as a termination mechanism for the signalling [<xref ref-type="bibr" rid="CR36">36</xref>]. Another balancing mechanism is the sympathicolytic effect seen in exercising skeletal muscle, which is important for increased blood flow in the working skeletal muscle during exercise, despite sympathetic NA release that normally would reduce blood flow. This sympathicolytic effect is mimicked by injection in the arterial lumen of ATP and UTP, inducing a vasodilatation that overrides sympathetic vasoconstrictor activity in human skeletal muscle, an effect not obtained by injection of adenosine [<xref ref-type="bibr" rid="CR37">37</xref>], suggesting that ATP and UTP may mediate this important physiological mechanism.</p>
        <p>The first evidence of the presence of P2 receptor subtypes suggested P2X receptors on vascular smooth muscle cells (VSMC) and P2Y receptors on endothelial cells [<xref ref-type="bibr" rid="CR38">38</xref>]. Rat blood vessel immunohistochemistry and human mRNA quantification have shown the P2X<sub>1</sub> receptor to be the highest expressed subtype in smooth muscle cells [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. It has been difficult to prove the importance of other contractile P2X receptors besides P2X<sub>1</sub> due to the paucity of specific agonists and antagonists. However, contractile effects of UTP suggested that P2Y receptors were present on VSMCs and mediated contraction [<xref ref-type="bibr" rid="CR41">41</xref>]. Using selective pyrimidines resistant to degradation, it has been possible to show that contractile effects are mediated by both UTP-sensitive P2Y<sub>2</sub> and UDP-sensitive P2Y<sub>6</sub> receptors [<xref ref-type="bibr" rid="CR42">42</xref>]. Ectonucleotidases in the vessel wall rapidly degrade nucleotides and markedly reduce their contractile effects. Pyrimidine analogues more resistant to ectonucleotidases are powerful vasoconstrictors and up to 1,000-fold more potent than the endogenous ligands [<xref ref-type="bibr" rid="CR42">42</xref>]. Similarly, a prominent more potent UDP contraction has been seen in NTPDase1 knockout mice, demonstrating the protective effect of ectonucleotidases against nucleotide contraction [<xref ref-type="bibr" rid="CR43">43</xref>]. In human saphenous vein grafts, used during coronary bypass, a stable UDP analogue stimulates a strong contraction lasting for hours, which is not desensitised [<xref ref-type="bibr" rid="CR44">44</xref>]. The reason why the P2Y<sub>6</sub> receptor is not desensitised is the lack of serine residues in the C-terminal part of the P2Y<sub>6</sub> receptor [<xref ref-type="bibr" rid="CR45">45</xref>]. Neither &#x3B1;<sub>1</sub>-adrenoceptors, nor P2Y<sub>6</sub> receptors, are present in human coronary arteries, possibly to avoid deleterious vasospasm during ischaemia [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
        <p>VSMC express P2Y<sub>12</sub> receptors that mediate contraction after stimulation with ADP [<xref ref-type="bibr" rid="CR46">46</xref>]. At the mRNA level, the P2Y<sub>12</sub> receptor is the highest expressed ADP receptor and the second highest expressed P2 receptor in human VSMC [<xref ref-type="bibr" rid="CR46">46</xref>]. The contractions are not inhibited in patients medicated with clopidogrel. However, drugs with antagonistic effects on P2Y<sub>12</sub> receptors that reach the peripheral circulation (AZD6140 and INS50589), affecting both platelets and VSMC, could be of double therapeutic benefit in their prevention of both thrombosis and vasospasm [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
        <p>In conclusion, extracellular nucleotides mediate vasoconstriction when released from nerves on the adventitial side, or when released in the lumen when the endothelium is damaged (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The most important contractile receptors on the VSMC are the ATP P2X<sub>1</sub> receptor, the ATP/UTP P2Y<sub>2</sub> receptor, the UDP P2Y<sub>6</sub> receptor and the ADP P2Y<sub>12</sub> receptor (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> and Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). To determine the relative physiological importance of these receptor subtypes in different human vascular beds is an important task for the future.
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>P2 receptor expression in the cardiovascular system</p></caption><table frame="hsides" rules="groups"><thead><tr><th>P2 subtype</th><th>Endothelium</th><th>VSMC</th><th>Heart</th><th>Platelets</th><th>Red blood cells</th><th>Inflammatory cells</th><th>Perivascular sensory nerves</th><th>Perivascular sympathetic nerves</th></tr></thead><tbody><tr><td>P2Y<sub>1</sub></td><td>High</td><td>&#x2013;</td><td>&#x2013;</td><td>High</td><td>(Turkey)</td><td/><td>Medium</td><td>Medium (neg. feedback)</td></tr><tr><td>P2Y<sub>2</sub></td><td>High</td><td>High</td><td>High</td><td>&#x2013;</td><td>&#x2013;</td><td>High</td><td>Low</td><td>Possible</td></tr><tr><td>P2Y<sub>4</sub></td><td>&#x2013;</td><td>Possible</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td/><td/></tr><tr><td>P2Y<sub>6</sub></td><td>Medium</td><td>Medium</td><td>High</td><td>&#x2013;</td><td>&#x2013;</td><td/><td/><td/></tr><tr><td>P2Y<sub>11</sub></td><td>Possible</td><td>&#x2013;</td><td>High</td><td>&#x2013;</td><td>&#x2013;</td><td>High</td><td/><td/></tr><tr><td>P2Y<sub>12</sub></td><td>&#x2013;</td><td>Medium</td><td>&#x2013;</td><td>High</td><td>&#x2013;</td><td>Low</td><td/><td/></tr><tr><td>P2Y<sub>13</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>High</td><td>Low</td><td/><td/></tr><tr><td>P2Y<sub>14</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td/><td/></tr><tr><td>P2X<sub>1</sub></td><td>&#x2013;</td><td>High</td><td>Medium</td><td>High</td><td>&#x2013;</td><td>Medium</td><td/><td/></tr><tr><td>P2X<sub>2</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td>High</td><td>Medium (pos. feedback)</td></tr><tr><td>P2X<sub>3</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td>High</td><td/></tr><tr><td>P2X<sub>4</sub></td><td>High</td><td>&#x2013;</td><td>Low</td><td>&#x2013;</td><td>&#x2013;</td><td>High</td><td/><td/></tr><tr><td>P2X<sub>5</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td/><td/></tr><tr><td>P2X<sub>6</sub></td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td/><td/><td/></tr><tr><td>P2X<sub>7</sub></td><td>&#x2013;</td><td>Possible</td><td>&#x2013;</td><td>&#x2013;</td><td>Low</td><td>High</td><td/><td/></tr></tbody></table><table-wrap-foot><p>Unless specified data refer to human tissue. High, medium or low expression represents an effort to summarise the results of a large number of mRNA, protein and pharmacological studies. Dash (&#x2013;) denotes lack of convincing evidence for expression. <italic>VSMC</italic> vascular smooth muscle cell</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Endothelial regulation</title>
        <p>Shear stress and hypoxia are important stimuli of both ATP and UTP release from endothelial cells [<xref ref-type="bibr" rid="CR47">47</xref>] (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Extracellular nucleotides have several important effects mediated by activation of endothelial cells. Vasodilatation and decreased blood pressure by release of prostaglandins and NO has been demonstrated in several studies [<xref ref-type="bibr" rid="CR5">5</xref>], but P2 receptors also mediate release of endothelium-derived hyperpolarising factor (EDHF), which relaxes VSMC by activation of potassium channels, with subsequent hyperpolarisation [<xref ref-type="bibr" rid="CR48">48</xref>&#x2013;<xref ref-type="bibr" rid="CR50">50</xref>]. Both UTP and ATP reduce forearm vascular resistance in a prostaglandin and NO independent way [<xref ref-type="bibr" rid="CR51">51</xref>], indicating an important role for EDHF in P2 receptor-mediated vasodilatation in man.</p>
        <p>The P2Y<sub>1</sub> receptor seems to be of major importance in most vascular beds [<xref ref-type="bibr" rid="CR11">11</xref>]. However, several other P2 receptors are important for endothelial regulation. Pharmacology of vasodilatation and mRNA quantification in man indicates that P2Y<sub>2</sub> and to a lesser degree P2Y<sub>6</sub> also are important endothelial P2Y receptors [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Knockout mice experiments recently confirmed this picture and demonstrated that the P2Y<sub>4</sub> receptor does not mediate dilatation [<xref ref-type="bibr" rid="CR53">53</xref>]. UTP and ATP are equipotent as vasodilators when infused in the human forearm circulation, indicating a role for both purinergic and pyrimidinergic receptors.</p>
        <p>The P2X<sub>1</sub> receptor is not expressed on the vascular endothelium and the evidence for other P2X receptors has been scarce, except for the P2X<sub>4</sub> receptor which is the highest expressed P2 receptor in endothelium [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Using antisense oligonucleotides the P2X<sub>4</sub> receptor was shown to be important for shear stress-dependent Ca<sup>2+</sup> influx via an ATP-dependent mechanism [<xref ref-type="bibr" rid="CR55">55</xref>]. This indicates that ATP and P2 receptors may be of importance for shear stress-mediated effects, which is in agreement with the well-established release of ATP from endothelial cells during shear stress [<xref ref-type="bibr" rid="CR56">56</xref>]. Vessel dilation induced by acute increases in blood flow is markedly suppressed in P2X<sub>4</sub> receptor knockout mice [<xref ref-type="bibr" rid="CR57">57</xref>]. Thus, endothelial P2X<sub>4</sub> channels are crucial to flow-sensitive mechanisms that regulate blood pressure and vascular remodelling [<xref ref-type="bibr" rid="CR57">57</xref>].</p>
        <p>Extracellular ATP in the circulation is rapidly degraded into ADP, AMP and adenosine by ectonucleotidases. Vascular NTPDase1 (CD39) is an endothelial cell membrane protein with both ecto-ATPase and ecto-ADPase activities [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Ectonucleotidases are also released by shear stress from endothelial cells [<xref ref-type="bibr" rid="CR59">59</xref>].</p>
        <p>Reactive hyperaemia is the massive increase in blood flow that starts when a blood vessel is opened after a period of ischaemia. It is well known that ATP is released during ischaemia [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Adenosine only mediates the late phase of the reactive hyperaemia as has been shown by infusion of adenosine deaminase or a selective A<sub>2A</sub> antagonist [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]; ADP has been shown to mediate the mid-portion and peak of coronary reactive hyperaemia via endothelial P2Y<sub>1</sub> receptors [<xref ref-type="bibr" rid="CR63">63</xref>]. It has been proposed that different purines may mediate three phases of the reactive hyperaemia [<xref ref-type="bibr" rid="CR63">63</xref>]. According to this hypothesis, ATP would mediate the first part of the hyperaemia via endothelial P2Y<sub>2</sub> or P2X<sub>4</sub> receptors. ATP would then be degraded to ADP, which mediates peak hyperaemia via endothelial P2Y<sub>1</sub> receptors, followed by degradation of ADP to adenosine resulting in late phase hyperaemia mediated via A<sub>2A</sub> receptors on smooth muscle cells.</p>
      </sec>
      <sec id="Sec5">
        <title>Red blood cells as regulators of vascular tone</title>
        <p>The matching of oxygen supply with demand requires a mechanism that increases blood flow in response to decreased tissue oxygen levels. Several reports suggest that the red blood cell (RBC) acts as a sensor for hypoxia and different mechanisms have been suggested by which the deoxygenated RBC stimulates vasodilatation [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR64">64</xref>&#x2013;<xref ref-type="bibr" rid="CR66">66</xref>]. RBCs contain millimolar amounts of ATP and possess the membrane-bound glycolytic enzymes necessary for its production [<xref ref-type="bibr" rid="CR67">67</xref>&#x2013;<xref ref-type="bibr" rid="CR69">69</xref>]. ATP is released in response to reductions in oxygen tension and pH [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] (see Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). It has been shown in vitro that vessels dilate in response to low O<sub>2</sub> levels only when blood vessels are perfused with RBCs [<xref ref-type="bibr" rid="CR70">70</xref>]. ATP is released in working human skeletal muscle circulation depending on the number of unoccupied haemoglobin O<sub>2</sub> binding sites [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Similar results have been shown in the coronary circulation of dogs [<xref ref-type="bibr" rid="CR72">72</xref>]. The released ATP then binds to P2Y receptors on the endothelium and stimulates vasodilatation. Thus, the RBC functions as an O<sub>2</sub> sensor, contributing to the regulation of blood flow and O<sub>2</sub> delivery, by releasing ATP depending on the oxygenation state of haemoglobin.
<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Release of purines and pyrimidines in the cardiovascular system</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Source</th><th>Endothelium</th><th>VSMC</th><th>Heart</th><th>Platelets</th><th>Red blood cells</th><th>Inflammatory cells</th><th>Vascular nerves</th></tr></thead><tbody><tr><td>Stimuli</td><td>Shear stress, hypoxia, high glucose</td><td>High glucose, hypoxia</td><td>Hypoxia</td><td>Collagen, thromboxane, other platelet activators</td><td>Hypoxia, adrenaline, deformation</td><td>Infl. activators</td><td>Sympathetic nerves, sensory nerve collaterals</td></tr><tr><td>Mechanism</td><td>Vesicular</td><td>Unknown</td><td>Unknown</td><td>Vesicular</td><td>Unknown</td><td>Unknown or vesicular</td><td>Vesicular</td></tr><tr><td>Nucleotide</td><td>ATP, UTP</td><td>ATP, UTP</td><td>ATP, UTP</td><td>ADP &gt; ATP</td><td>ATP</td><td>ATP</td><td>ATP</td></tr><tr><td>Target</td><td>Endothelium VSMC</td><td>VSMC</td><td>Cardiomyocytes, blood vessels, intrinsic cardiac neurons</td><td>Platelets; endothelium or VSMC</td><td>Endothelium</td><td>VSMC, endothelium</td><td>VSMC</td></tr><tr><td>Degradation</td><td>NTPDase1</td><td>NTPDase2, NTPDase1</td><td>NTPDase1</td><td>NTPDase1</td><td>NTPDase1</td><td>NTPDase1</td><td>NTPDase1 (co-released)</td></tr></tbody></table><table-wrap-foot><p><italic>Stimuli</italic> represents stimuli leading to release. <italic>Mechanism</italic> refers to mechanism of release at the cellular level. <italic>Target</italic> represents the cells that are regulated by the released purine or pyrimidine. <italic>Degradation</italic> refers to the degrading enzyme responsible for removing the purine or pyrimidine after the release. <italic>VSMC</italic> vascular smooth muscle cell</p></table-wrap-foot></table-wrap></p>
        <p>ADP activates a negative feedback pathway for ATP release from human RBCs via P2Y<sub>13</sub> receptors [<xref ref-type="bibr" rid="CR73">73</xref>]. Since blood consists of approximately 40% RBCs that contain a 1,000-fold higher ATP concentration than plasma (mmol/l vs &#x3BC;mol/l), even a minor release of ATP from the high intracellular concentrations could have major circulatory effects. A negative feedback system may therefore be of great physiological importance to mitigate ATP release. Another negative feedback system is the mechanism by which NO inhibits ATP release from erythrocytes, illustrating how NO may turn off ATP release [<xref ref-type="bibr" rid="CR74">74</xref>]. NO is then scavenged by haemoglobin.</p>
        <p>Furthermore, the previous view of the RBC as a &#x201C;passive bag that transports oxygen&#x201D; is challenged. It now turns out that it releases ATP in response to stimuli and, as with most important signalling systems, it has a negative feedback system to terminate its release. The described negative feedback pathway may be important to avoid high extracellular concentrations of ATP. At levels above 100&#xA0;&#xB5;mol/l, ATP concentrations may exceed the catalytic capacity of ectonucleotidases and could, in fact, stimulate ATP release by increasing permeability of the RBC [<xref ref-type="bibr" rid="CR75">75</xref>], probably via P2X<sub>7</sub> receptors [<xref ref-type="bibr" rid="CR76">76</xref>]. ATP may even release ATP from endothelial cells [<xref ref-type="bibr" rid="CR77">77</xref>]. At high concentrations of ATP, a self-sustaining process may thus be instigated which may contribute to the irreversible stage of circulatory shock that can develop rapidly in severely ill patients. Similar mechanisms may be of importance in malaria because induction of the osmolyte permeability in <italic>Plasmodium</italic>-infected erythrocytes involves purinoceptor signalling [<xref ref-type="bibr" rid="CR78">78</xref>].</p>
        <p>A mechanism of ATP release from RBCs, which has eluded researchers for many years, has recently been suggested by Locovei and co-workers as being mediated via the gap junction protein pannexin-1 [<xref ref-type="bibr" rid="CR79">79</xref>]. Erythrocytes do not form gap junctions, instead pannexin-1 forms a mechanosensitive ATP-permeable channel that mediates osmotically induced ATP release.</p>
      </sec>
      <sec id="Sec6">
        <title>Hypertension</title>
        <p>Blood pressure regulation by purinergic signalling is the net result of balancing contractile and dilatory effects as described above. ATP and UTP released on the luminal side, from endothelial cells and erythrocytes, stimulate vasodilatation, in contrast to release from nerves on the adventitial side, which results in vasoconstriction. ATP may also regulate blood pressure via renal mechanisms or brain stem regulation [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>].</p>
        <p>ATP plays a significantly greater role as a sympathetic cotransmitter in spontaneously hypertensive rats (SHR) [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>], and there is increased responsiveness of the renal vasculature of isolated perfused rat kidneys to &#x3B1;,&#x3B2;-methylene ATP in SHR [<xref ref-type="bibr" rid="CR82">82</xref>], while mesenteric vascular contractile reactivity to ATP via P2X<sub>1</sub> and P2Y<sub>2</sub> receptors is not altered in deoxycorticosterone acetate (DOCA)-salt hypertension [<xref ref-type="bibr" rid="CR83">83</xref>]. In the aorta of SHR, endothelium-dependent relaxation to ATP is impaired because of the concomitant generation of an endothelium-derived contracting factor. Contractions to ATP were significantly potentiated in SHR aorta [<xref ref-type="bibr" rid="CR84">84</xref>]. In hypertensive mature stroke-prone rats, NPY modulation of release of NA and ATP from sympathetic perivascular nerves in kidney vessels is impaired, which may account for the increased nerve-mediated responses [<xref ref-type="bibr" rid="CR85">85</xref>]. Thus, animal models of hypertension reveal several alterations in purinergic signalling that may contribute to the development of hypertension.</p>
        <p>Diadenosine polyphosphates such as Ap<sub>4</sub>A, Ap<sub>5</sub>A and Ap<sub>6</sub>A are combinations of two adenosine molecules connected with four to six phosphate groups. They have been identified as vasocontractile agents [<xref ref-type="bibr" rid="CR86">86</xref>], probably via actions on P2X<sub>1</sub> and P2Y<sub>2</sub> receptors. Ap<sub>5</sub>A and Ap<sub>6</sub>A are stored at higher levels in platelets from patients with hypertension and may contribute to their increased peripheral vascular resistance [<xref ref-type="bibr" rid="CR87">87</xref>]. Up<sub>4</sub>A is a novel endothelium-derived vasoconstrictive factor more potent than endothelin in renal vasoconstriction [<xref ref-type="bibr" rid="CR88">88</xref>]. It is released upon stimulation of the endothelium by acetylcholine, thrombin and mechanical stress and can be cleaved into either ATP or UTP to stimulate both P2X<sub>1</sub> and P2Y<sub>2</sub> receptors on VSMC resulting in increased blood pressure [<xref ref-type="bibr" rid="CR88">88</xref>].</p>
        <p>As mentioned above, the P2X<sub>4</sub> receptor is the most abundantly expressed P2 receptor in the endothelium and mediates shear stress-stimulated vasodilatation. P2X<sub>4</sub> receptor knockout mice have higher blood pressures and excrete smaller amounts of NO products in their urine than do wild-type mice [<xref ref-type="bibr" rid="CR57">57</xref>]. The P2X<sub>4</sub> receptor protein is upregulated in the placenta in preeclampsia [<xref ref-type="bibr" rid="CR89">89</xref>]. Thus, shear stress-stimulated release of ATP acting on P2X<sub>4</sub> receptors may be important for blood pressure regulation.</p>
        <p>The importance of P2 receptors for hypertension will not be proven until tested in man. It would be of great interest to perform a clinical study on the effects of P2X<sub>1</sub>, P2Y<sub>2</sub> or P2Y<sub>6</sub> receptor antagonists in the treatment of hypertension.</p>
      </sec>
      <sec id="Sec7">
        <title>Pulmonary hypertension</title>
        <p>Erythrocyte release of ATP appears to regulate pulmonary resistance under some conditions [<xref ref-type="bibr" rid="CR90">90</xref>], and patients with pulmonary hypertension have been found with impaired release of ATP from RBC [<xref ref-type="bibr" rid="CR69">69</xref>]. Endothelium-dependent relaxation to ATP has been demonstrated in human pulmonary arteries [<xref ref-type="bibr" rid="CR91">91</xref>]. On the other hand, ATP is a mitogen for pulmonary artery smooth muscle cells, which may be relevant for the pathophysiological basis of pulmonary hypertension [<xref ref-type="bibr" rid="CR92">92</xref>]. Again, the balance between endothelial versus smooth muscle stimulation by ATP may regulate blood pressure in different directions and we are far from a full understanding of the role of the purinergic system in pulmonary hypertension.</p>
      </sec>
      <sec id="Sec8">
        <title>Migraine and vascular pain</title>
        <p>Classic migraine is associated with two distinct vascular changes: an initial vasoconstriction, followed by vasodilatation associated with pain. It has been proposed that purinergic signalling is involved in these changes. ATP released from perivascular sympathetic nerves may participate in producing the initial vasospasm mediated by P2 receptors in vascular smooth muscle. Cerebral arteries are strongly contracted by UTP and especially UDP via P2Y<sub>6</sub> receptors. A UDP agonist might therefore have similar effects as the 5-HT<sub>1D</sub> agonists frequently used to treat migraine [<xref ref-type="bibr" rid="CR93">93</xref>]. ATP released by endothelial cells acting on P2 receptors on endothelial cells mediating release of NO and producing vasodilatation may contribute to the phase of reactive hyperaemia following vasospasm [<xref ref-type="bibr" rid="CR94">94</xref>]. It has been suggested that antagonists to P2X<sub>3</sub> receptors, which are located on nociceptive sensory nerve endings in cerebral vessels, may be promising candidates for anti-migraine drug development [<xref ref-type="bibr" rid="CR95">95</xref>]. A recent report demonstrates selective upregulation of nociceptive P2X<sub>3</sub> receptors on trigeminal neurons by calcitonin gene-related peptide and suggests that this mechanism might contribute to pain sensitisation in migraine [<xref ref-type="bibr" rid="CR96">96</xref>]. P2Y receptors on trigeminal sensory nerves have also been implicated in pain in migraine. It has been claimed that migraine attacks are characterised by a relative depletion of sympathetic NA stores in conjunction with an increase in release of ATP [<xref ref-type="bibr" rid="CR97">97</xref>]. In a review in the <italic>Lancet</italic> in 1996, Burnstock proposed that vascular pain, as in angina, ischaemic muscle and pelvic pain in women, may be initiated by ATP released from microvascular endothelial cells during reactive hyperaemia, diffusing a short distance to activate P2X<sub>3</sub> nociceptive receptors on sensory nerves in the adventitia [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Atherosclerosis</title>
      <p>Atherosclerosis is the main cause of ischaemic stroke and cardiovascular disease and is now considered to be an inflammatory disease [<xref ref-type="bibr" rid="CR98">98</xref>]. The formation of a plaque starts with the accumulation of cholesterol followed by invasion of macrophages taking up cholesterol and becoming foam cells. The plaque can be stabilised by smooth muscle cell formation of a fibrous cap that covers the lipid-rich region. However, stimulation of inflammation by oxidised low-density lipoprotein activates macrophages and dendritic cells into antigen-presenting cells, activating T lymphocytes resulting in release of cytokines and metalloproteinases degrading the fibrous cap. The end result is a vulnerable plaque and, when it ruptures, its highly thrombogenic contents activates platelets and causes the formation of a local thrombus occluding the artery or embolising, resulting in ischaemic stroke or myocardial infarction. Evidence both from basic research and from clinical studies indicates important involvement on several levels for purinergic signalling in the atherosclerotic process (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Interestingly, fish oil components increase the release of ATP [<xref ref-type="bibr" rid="CR99">99</xref>] and a high cholesterol diet decreases ATP release from arteries [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>].
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Functional roles of P2 receptors in the atherosclerotic inflammatory plaque and during restenosis. See text for details. Purines and pyrimidines acting on P2 receptors stimulate vascular inflammation both by actions on the endothelial cell (<italic>EC</italic>) and by effects on inflammatory cells. Furthermore, they stimulate vascular smooth muscle cell (<italic>VSCM</italic>) proliferation, the conversion to synthetic phenotype and production of matrix proteins. Mitogenic P2 receptors are upregulated by growth factors and cytokines. <italic>IL</italic> interleukin, <italic>MCP-1</italic> monocyte chemoattractant protein-1, <italic>ICAM-1</italic> intercellular adhesion molecule-1, <italic>TSP</italic> thrombospondin, <italic>IDO</italic> indoleamine 2,3-dioxygenase</p></caption><graphic position="anchor" xlink:href="11302_2007_9078_Fig2_HTML" id="MO2"/></fig></p>
      <sec id="Sec10">
        <title>Atherosclerosis&#x2014;P2 receptor-mediated effects on inflammatory cells</title>
        <p>Inflammatory cells express a large number of P2 receptors with multiple effects [<xref ref-type="bibr" rid="CR102">102</xref>]. The final result is difficult to predict depending on the subtype of receptor expressed by a particular cell type and on the differentiation stage of the cell. The most important inflammatory cells for atherosclerosis are monocytes that differentiate into macrophages or dendritic cells in the plaque, and the T-helper and suppressor lymphocytes that coordinate the inflammatory reaction in the plaque [<xref ref-type="bibr" rid="CR98">98</xref>].</p>
        <p>A large number of P2 receptors are expressed on T lymphocytes and macrophages [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR103">103</xref>] and have been suggested to be important players in atherosclerosis [<xref ref-type="bibr" rid="CR14">14</xref>]. Strong evidence for a functional role exists for P2X<sub>7</sub>, P2Y<sub>2</sub> and P2Y<sub>11</sub> receptors. The P2X<sub>7</sub> receptor is mitogenic and anti-apoptotic for T lymphocytes [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. P2X<sub>7</sub> is important for release of interleukin (IL)-1 [<xref ref-type="bibr" rid="CR106">106</xref>], tumour necrosis factor [<xref ref-type="bibr" rid="CR107">107</xref>] and <sc>L</sc>-selectin, an adhesion molecule important for lymphocyte binding to endothelium [<xref ref-type="bibr" rid="CR108">108</xref>]. All of these effects are known to be important for atherosclerosis development. The severity of arthritis is reduced in P2X<sub>7</sub> receptor knockout mice [<xref ref-type="bibr" rid="CR109">109</xref>] and rheumatoid arthritis is coupled to increased incidence of myocardial infarction. It would be of great interest to examine the P2X<sub>7</sub> receptor knockout mouse in an atherosclerosis model. ATP and UTP are chemotactic for dendritic cells probably via the P2Y<sub>2</sub> receptor and may attract inflammatory cells to the vascular lesion [<xref ref-type="bibr" rid="CR110">110</xref>]. The P2Y<sub>2</sub> receptor enhances the oxidative burst in human macrophages [<xref ref-type="bibr" rid="CR111">111</xref>]. P2Y<sub>1</sub> receptor deletion in knockout mice reduces the atherosclerotic lesions and the plaque area occupied by macrophages in ApoE knockout mice [<xref ref-type="bibr" rid="CR112">112</xref>]. Whether this is due to platelet inhibition, endothelial or an inflammatory mechanism requires further studies.</p>
        <p>ATP inhibits CD4+ T cell activation via an increase in cyclic AMP (cAMP) probably via a P2Y<sub>11</sub> receptor [<xref ref-type="bibr" rid="CR113">113</xref>]. ATP acting on P2Y<sub>11</sub> receptors regulates the maturation of human monocyte-derived dendritic cells and induces immunosuppression by inhibiting T-helper 1 cytokines and promoting T-helper 2 cytokines [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>].</p>
        <p>A polymorphism in the P2Y<sub>11</sub> receptor has been shown to have clinical importance by increasing the risk of myocardial infarction [<xref ref-type="bibr" rid="CR116">116</xref>]. The G-459-A polymorphism, carried by one fifth of the population, causes an Ala-87-Thr substitution in the P2Y<sub>11</sub> ATP receptor and increases the risk of myocardial infarction by 21%. The odds ratio increased stepwise depending on the number of Thr-87 alleles, and in subgroups in which the genetic influence is known to be of increased importance, family history of acute myocardial infarction (AMI), early onset AMI or the combined group of early onset AMI with family history. The mechanism by which the polymorphism causes AMI seems to be coupled to increased inflammation because the Thr-87 variant of the P2Y<sub>11</sub> receptor was coupled to elevated C-reactive protein (CRP) levels. CRP is a marker of inflammation and an independent prognostic risk factor for the development of AMI [<xref ref-type="bibr" rid="CR98">98</xref>]. Thus, the P2Y<sub>11</sub> receptor is important in the development of atherosclerosis via modulation of inflammation either via effects on T lymphocytes or macrophage cells.</p>
      </sec>
      <sec id="Sec11">
        <title>Proinflammatory effects on the endothelium</title>
        <p>Even though P2 receptor-mediated activation of the endothelium stimulates release of NO, which inhibits inflammatory cells, it is now well established that important proinflammatory endothelial effects may also be triggered. A proinflammatory dysfunctional endothelium is crucial in the recruitment of monocytes to the atherosclerotic plaque and in the general extravasation and loss of peripheral resistance seen in sepsis. ATP stimulates neutrophil adherence to cultured endothelial cells [<xref ref-type="bibr" rid="CR117">117</xref>]. ATP stimulates release of IL-6, IL-8, monocyte chemoattractant protein-1, growth-regulated oncogene &#x3B1; and increased expression of intercellular adhesion molecule-1 in human microvascular endothelial cells [<xref ref-type="bibr" rid="CR118">118</xref>]. UTP and ATP stimulate expression of proinflammatory vascular cell adhesion molecule-1 (VCAM-1) in endothelial cells through activation of the P2Y<sub>2</sub> receptor and increases the adherence of monocytic cells to human coronary endothelial cells, an effect that was inhibited by anti-VCAM-1 antibodies [<xref ref-type="bibr" rid="CR119">119</xref>]. VCAM is important for the recruitment of monocytes and lymphocytes. The VCAM stimulation is caused by P2Y<sub>2</sub> receptor-induced transactivation of the vascular endothelial growth factor receptor-2 [<xref ref-type="bibr" rid="CR120">120</xref>]. These effects have been confirmed in an in vivo neointima model, in which perivascular infusion of UTP enhanced infiltration by macrophages [<xref ref-type="bibr" rid="CR121">121</xref>].</p>
        <p>In conclusion, ATP and UTP stimulate several inflammatory responses known to be important for atherosclerosis development (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).</p>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>Restenosis and vascular smooth muscle cell proliferative disease</title>
      <p>VSMC proliferation contributes to plaque development, but it is probably beneficial by stabilising the plaque and forming a stronger fibrinous cap. However, there are several situations in which VSMC proliferation is important in vascular disease development: restenosis after balloon angioplasty, diabetic microvascular disease, chronic allograft rejection, pulmonary hypertension and possibly systemic hypertension. The latter is suggested since sympathetic nerves exert a trophic effect on vascular smooth muscle [<xref ref-type="bibr" rid="CR122">122</xref>]. ATP is a cotransmitter from sympathetic nerves [<xref ref-type="bibr" rid="CR25">25</xref>] and has been shown to be a more potent mitogen than the other cotransmitters NA and NPY [<xref ref-type="bibr" rid="CR123">123</xref>].</p>
      <p>Extracellular ATP is a potent growth factor for VSMC by activation of G protein-coupled P2Y receptors [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR123">123</xref>&#x2013;<xref ref-type="bibr" rid="CR125">125</xref>]. UTP is also mitogenic, acting on P2Y<sub>2</sub> receptors [<xref ref-type="bibr" rid="CR123">123</xref>], as is UDP acting on P2Y<sub>6</sub> receptors [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. ATP is synergistic with polypeptide growth factors (e.g. platelet-derived growth factor, basic fibroblast growth factor) and insulin [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. The signal transduction is mediated via Gq proteins, phospholipase C and D, diacylglycerol, protein kinase C, extracellular signal-regulated kinase, phosphatidylinositol-3 kinase, MAPK/ERK activity kinase, mitogen-activated protein kinases and Rho [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]. Several immediate early genes are activated and the cell is taken through different phases of the cell cycle [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Sometimes, as with UDP acting on P2Y<sub>6</sub> receptors, progression is stimulated to both the S and G<sub>2</sub> phases, that is through the whole cell cycle [<xref ref-type="bibr" rid="CR127">127</xref>].</p>
      <p>Mitogenic effects have been demonstrated in rat, porcine, and bovine VSMC and cells from human coronary arteries, aorta, and subcutaneous arteries and veins [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. The trophic effects on VSMC and the abundant sources for extracellular ATP in the vessel wall make a pathophysiological role probable in the development of atherosclerosis, neointima formation after angioplasty, chronic allograft rejection, pulmonary hypertension, diabetic microvascular disease and possibly hypertension. In these processes interaction between the VSMC and the matrix is important. It is therefore interesting that the human P2Y<sub>2</sub> receptor contains an integrin-binding domain (RGD) in its first extracellular loop and that interaction with integrins influences P2Y<sub>2</sub> receptor-mediated activation of G proteins [<xref ref-type="bibr" rid="CR132">132</xref>]. ATP stimulates release of matrix metalloproteinase-2 (MMP-2) from human aortic smooth muscle cells and MMP-2 has been implicated in aortic aneurysm pathogenesis [<xref ref-type="bibr" rid="CR133">133</xref>]. MMPs open up the matrix for migrating VSMC. ATP and UTP are potent chemotactic agents stimulating VSMC migration via P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors [<xref ref-type="bibr" rid="CR134">134</xref>]. These mechanisms, together with growth-stimulating effects, explain why perivascular infusion of UTP in a neointima model enhanced neointimal development [<xref ref-type="bibr" rid="CR121">121</xref>]. Overexpression of the ATP- and UTP-degrading enzyme NTPDase1 reduces neointima development in rat aorta [<xref ref-type="bibr" rid="CR135">135</xref>]. Augmentation of NTPDase1 activity is an important adaptive response for cardiac allograft survival, with increased inflammation, platelet deposition and infarction rates in NTPDase-deficient mice [<xref ref-type="bibr" rid="CR136">136</xref>]. The mechanism is dependent on increased expression of the atherosclerotic matrix protein osteopontin [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR137">137</xref>].</p>
      <sec id="Sec13">
        <title>Diabetic microvascular disease</title>
        <p>Sympathetic vascular dysfunction in early experimental juvenile diabetes was recognised many years ago. Two weeks after induction of streptozotocin diabetes in rats, there was prejunctional impairment of sympathetic neurotransmission and impaired ATP-mediated endothelial function in mesenteric arteries [<xref ref-type="bibr" rid="CR138">138</xref>]. Altered relaxant responses to ATP in the corpus cavernosum of men and rats with diabetes have also been reported [<xref ref-type="bibr" rid="CR139">139</xref>].</p>
        <p>As mentioned above, red blood cells may stimulate vasodilatation via release of ATP, which may be important in maintaining perfusion in the microcirculation. Interestingly, in erythrocytes from humans with type 2 diabetes ATP release is impaired, which is consistent with the hypothesis that the defect in erythrocyte physiology could contribute to the vascular disease associated with this clinical condition [<xref ref-type="bibr" rid="CR140">140</xref>].</p>
        <p>High extracellular glucose releases ATP and/or UTP in endothelial cells and pancreatic &#x3B2; cells [<xref ref-type="bibr" rid="CR141">141</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. An increase in glucose from 5 to 15&#xA0;mmol/l results in a marked increase in the proatherogenic nuclear factor of activated T cells signalling pathway in VSMC [<xref ref-type="bibr" rid="CR143">143</xref>]. The effect is mediated via glucose-induced release of ATP and UTP, which subsequently activate P2Y<sub>2</sub> but also P2Y<sub>6</sub> receptors (after degradation to UDP). Thus, nucleotide release is a potential metabolic sensor for the arterial smooth muscle response to high glucose. Diabetic patients experience microvascular disease characterised by increased wall-lumen ratio, mainly because of an increase in VSMC and have higher rates of restenosis after coronary angioplasty. High glucose-induced release of extracellular nucleotides, acting on P2Y receptors to stimulate VSMC growth via NFAT (nuclear factor of activated T cells) activation, may provide a link between diabetes and diabetic vascular disease [<xref ref-type="bibr" rid="CR143">143</xref>].</p>
        <p>In conclusion, ATP/UTP/UDP stimulate VSMC growth, migration, release of MMPs and osteopontin that may contribute to the development of restenosis, diabetic microvascular disease, chronic allograft rejection, pulmonary hypertension and possibly systemic hypertension (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).</p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Vascular remodelling and angiogenesis</title>
      <sec id="Sec15">
        <title>Vascular remodelling</title>
        <p>P2 receptors may regulate VSMC phenotype and vice versa, and P2 receptor expression is markedly altered during phenotype changes [<xref ref-type="bibr" rid="CR13">13</xref>]. The shift from a specialised contractile VSMC phenotype into a proliferating, matrix-producing, synthetic phenotype is a prerequisite for VSMC pathogenesis in vascular disease. Pacaud and co-workers found that the Ca<sup>2+</sup>-mobilising effects of 2-methylthioATP increased in VSMC during culture in serum, indicating upregulation of P2Y<sub>1</sub> receptors in the transition from contractile to synthetic phenotype [<xref ref-type="bibr" rid="CR144">144</xref>]. This was confirmed at the mRNA level where P2Y<sub>2</sub> receptors were found to be upregulated, while P2X<sub>1</sub> receptors were downregulated [<xref ref-type="bibr" rid="CR145">145</xref>]. Mitogenic P2Y receptors are upregulated while ion channel receptors, with only contractile effects, are downregulated in the synthetic phenotype [<xref ref-type="bibr" rid="CR145">145</xref>]. Growth factors, cytokines and interestingly also ATP are potent stimulators of P2Y<sub>2</sub> receptor expression [<xref ref-type="bibr" rid="CR146">146</xref>, <xref ref-type="bibr" rid="CR147">147</xref>]. Thus, factors of importance in the development of vascular disease increase mitogenic P2Y<sub>2</sub> receptors; this is further supported by their upregulation in neointima after balloon angioplasty [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. ATP has a dual concentration-dependent effect on VSMC phenotype. Low ATP concentrations stimulate expression of genes specific for the contractile phenotype, while high ATP concentrations cause a phenotypic shift from the contractile to the synthetic phenotype, and this shift is dependent on a transient activation of protein kinase A, which inhibits activation of a serum response factor [<xref ref-type="bibr" rid="CR150">150</xref>]. This previously unrecognised mechanism also appears to be important for the profound mitogenic effect of ATP. In intact human blood vessels examined in vitro, shear stress decreased contractile P2X<sub>1</sub> receptor expression, but increased the expression of mitogenic P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors in VSMC [<xref ref-type="bibr" rid="CR151">151</xref>]. This mechanism could promote vascular growth and remodelling induced by shear stress as an adaptive response to increased flow. P2X<sub>4</sub> receptor knockout mice are incapable of adaptive vascular remodelling, that is, a decrease in vessel size in response to a chronic decrease in blood flow [<xref ref-type="bibr" rid="CR57">57</xref>].</p>
      </sec>
      <sec id="Sec16">
        <title>Angiogenesis</title>
        <p>Very little is known about the role of P2 receptors in angiogenesis, but there are some studies suggesting their involvement. Ischaemia stimulates release of ATP [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] and it has been shown to be a growth factor for endothelial cells [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. ATP and UTP stimulate cytoskeletal rearrangements with consequent cell migration of human endothelial cells [<xref ref-type="bibr" rid="CR153">153</xref>] and ATP stimulates vasa vasorum neovascularisation in pulmonary arteries [<xref ref-type="bibr" rid="CR154">154</xref>]. Newly developed vascular endothelia express very high levels of NTPDase1, also seen under hypoxic conditions [<xref ref-type="bibr" rid="CR155">155</xref>]. NTPDase1 knockout mice exhibit disordered cellular migration and angiogenesis [<xref ref-type="bibr" rid="CR156">156</xref>].</p>
      </sec>
      <sec id="Sec17">
        <title>Varicose veins</title>
        <p>It has been suggested that cell lysis, consequent to P2X<sub>7</sub> receptor-induced pore formation, contributes to the disorganisation and decrease in contractile myocytes in the media of varicose veins [<xref ref-type="bibr" rid="CR157">157</xref>]. Upregulation of P2Y<sub>1</sub> and P2Y<sub>2</sub> receptors and downregulation of P2X<sub>1</sub> receptors on smooth muscle of varicose veins is associated with a shift from contractile to synthetic and/or proliferative roles; this phenotypic change in smooth muscle leads to weakening of vein walls and may be a causal factor in the development of varicose veins [<xref ref-type="bibr" rid="CR158">158</xref>], an interesting parallel to the receptor changes seen in response to increased shear stress (see above) [<xref ref-type="bibr" rid="CR151">151</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec18">
      <title>Heart</title>
      <p>ATP is released in the heart as a cotransmitter together with catecholamines from sympathetic nerves, but it may also be released from other sources in the heart such as endothelium, platelets, RBC and ischaemic myocardium (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR159">159</xref>]. P2 receptors are abundantly expressed in the foetal human heart [<xref ref-type="bibr" rid="CR160">160</xref>] as well as in the adult human heart [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR161">161</xref>].</p>
      <sec id="Sec19">
        <title>Inotropy</title>
        <p>In cardiomyocytes, ATP stimulates a pronounced positive inotropic effect and may also act in synergy with &#x3B2;-adrenergic agonists to augment myocyte contractility [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR162">162</xref>&#x2013;<xref ref-type="bibr" rid="CR165">165</xref>]. ATP stimulates an increase in cytosolic calcium and evidence for the involvement of inositol 1,4,5-trisphosphate (IP<sub>3</sub>)-coupled P2Y<sub>2</sub> receptors and ion channel P2X receptors has been presented [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR164">164</xref>&#x2013;<xref ref-type="bibr" rid="CR167">167</xref>]. Ap<sub>4</sub>A, probably after degradation to ATP, increases force of contraction in human ventricular trabeculae [<xref ref-type="bibr" rid="CR168">168</xref>].</p>
        <p>The inotropic effects of ATP are dependent on both IP<sub>3</sub> and cAMP [<xref ref-type="bibr" rid="CR169">169</xref>]. The inotropic effects of catecholamines acting on &#x3B2;-receptors are mediated by an increase of cAMP and antagonists of these receptors are important drugs for the treatment of hypertension and reduce mortality in congestive heart failure. Similarly, ATP stimulates an increase in cAMP in cardiac myocytes and may act in synergy with the &#x3B2;<sub>1</sub>-adrenergic agonist, isoproterenol, by differential activation of adenylyl cyclase isoforms [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR170">170</xref>, <xref ref-type="bibr" rid="CR171">171</xref>]. However, the ATP receptor mediating this increase in cAMP has not been related to any particular P2 receptor subtype in cardiac cells [<xref ref-type="bibr" rid="CR60">60</xref>]. It could be the P2Y<sub>11</sub> receptor that is additionally coupled to G<sub>s</sub> and activates adenylyl cyclase [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR172">172</xref>&#x2013;<xref ref-type="bibr" rid="CR174">174</xref>]. mRNA for the P2Y<sub>11</sub> receptor has been detected in the human heart at high levels [<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR175">175</xref>].</p>
        <p>The unstable agonist, UTP, has been shown to induce a positive inotropic effect in rat atria and in rat and guinea pig ventricular cardiomyocytes [<xref ref-type="bibr" rid="CR164">164</xref>, <xref ref-type="bibr" rid="CR166">166</xref>, <xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>]. Stable UTP and UDP analogues induce a pronounced inotropic effect on mouse cardiomyocytes [<xref ref-type="bibr" rid="CR161">161</xref>]. The P2Y<sub>2</sub> receptor is the most abundantly expressed receptor with very low levels of the P2Y<sub>4</sub> receptor in the human heart [<xref ref-type="bibr" rid="CR161">161</xref>], suggesting that the inotropic effects of UTP are mediated via P2Y<sub>2</sub> receptors, while the UDP effects are mediated via the P2Y<sub>6</sub> receptor [<xref ref-type="bibr" rid="CR161">161</xref>]. These mechanisms are mediated via IP<sub>3</sub>-mediated signalling.</p>
        <p>In conclusion, the inotropic effects in man are mediated via P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors and a P2Y<sub>11</sub>-like receptor (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). P2X receptors are probably also involved, since several subtypes are expressed [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR160">160</xref>], but it has not been possible to perform a clear receptor characterisation due to lack of selective antagonists.
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Functional roles of purines and pyrimidines acting on P2 receptors in the regulation of the heart. See text for details. <bold>a</bold> ATP, UTP and UDP exert inotropic effects on cardiomyocytes leading to increased cardiac output. <bold>b</bold> UTP and UDP stimulate hypertrophy of cardiomyocytes, while ATP can have apoptotic effects. <bold>c</bold> UTP protects against ischaemic injury and cardiomyocyte cell death. ATP-degrading enzymes preserve endothelial integrity and protect against allograft rejection. <italic>NTPDase</italic> nucleoside triphosphate diphosphohydrolase</p></caption><graphic position="anchor" xlink:href="11302_2007_9078_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec20">
        <title>Myocardial infarction</title>
        <p>Using microdialysis, ATP in the interstitial space has been estimated to be 40&#xA0;nmol/l, but the levels may increase markedly during electrical stimulation, ischaemia, challenge with cardiotonic agents, increase in blood flow, mechanical stretch and increased work load [<xref ref-type="bibr" rid="CR60">60</xref>]. ATP is released from cardiomyocytes during reduced oxygen tension [<xref ref-type="bibr" rid="CR60">60</xref>]. UTP and ATP are released from the heart during cardiac ischaemia [<xref ref-type="bibr" rid="CR178">178</xref>] and patients with myocardial infarction have higher plasma levels of both ATP and UTP [<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR179">179</xref>]. There is a significant increase in ectonucleotidase activity (NTPDase1) in the hearts of patients with ischaemic heart disease [<xref ref-type="bibr" rid="CR180">180</xref>] that could represent a compensatory mechanism against increased nucleotide levels during chronic ischaemia.</p>
        <p>Ischaemia-reperfusion provokes barrier failure of the coronary microvasculature, leading to myocardial oedema, ATP may protect against reperfusion-induced coronary endothelial barrier damage and inhibition of ATP degradation enhances the stabilising effect of ATP on barrier function [<xref ref-type="bibr" rid="CR181">181</xref>].</p>
        <p>The common P2Y<sub>11</sub> ATP receptor polymorphism, Ala-87-Thr, is associated with both increased CRP and increased risk of developing myocardial infarction [<xref ref-type="bibr" rid="CR116">116</xref>]. Based on this association, we hypothesise that the P2Y<sub>11</sub> receptor plays an important role in cardiovascular biology and in inflammatory disease (see above), causing myocardial infarction via a proinflammatory effect. However, increased inotropic effects may also contribute.</p>
        <p>An interesting yin and yang situation for ATP and UTP has been revealed regarding hypertrophic effects. UTP but not ATP causes hypertrophic growth in neonatal cardiomyocytes [<xref ref-type="bibr" rid="CR182">182</xref>] (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). In contrast, ATP inhibits hypertrophy and may even induce apoptosis and necrosis [<xref ref-type="bibr" rid="CR163">163</xref>, <xref ref-type="bibr" rid="CR183">183</xref>]. The reason for the difference in effects could be due to activation of P2X receptors or cAMP stimulation by ATP [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR161">161</xref>]. Both UTP and ATP transactivate epidermal growth factor receptors, but only ATP stimulates the hypertrophic marker genes atrial natriuretic peptide and myosin light chain 2 [<xref ref-type="bibr" rid="CR184">184</xref>]. Similarly, UTP but not ATP protects cultured cardiomyocytes against hypoxic stress [<xref ref-type="bibr" rid="CR185">185</xref>]. Since UTP is released during preconditioning [<xref ref-type="bibr" rid="CR178">178</xref>], a role for UTP in the protective effects of preconditioning is plausible. Recently, Yitzhaki and co-workers were able to demonstrate prominent reductions in myocardial infarction size and improved rat heart function in vivo, by a single intravenous bolus dose of UTP before ischaemia [<xref ref-type="bibr" rid="CR186">186</xref>] (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>).</p>
      </sec>
      <sec id="Sec21">
        <title>Congestive heart failure</title>
        <p>There are several reports of alterations or adaptations of purinergic signalling during congestive heart failure. The positive inotropic effect of ATP is impaired in heart failure, but reversed by the angiotensin-converting enzyme (ACE)inhibitor imidapril [<xref ref-type="bibr" rid="CR187">187</xref>]. The contractile responses for the P2Y<sub>11</sub> receptor agonist AR-C67085 are decreased in heart failure, suggesting a downregulation of this receptor function in cardiomyocytes in a similar manner as seen for &#x3B2;<sub>1</sub>-receptors in congestive heart failure [<xref ref-type="bibr" rid="CR169">169</xref>]. In human hearts, only the P2X<sub>6</sub> receptor was altered in congestive heart failure [<xref ref-type="bibr" rid="CR188">188</xref>]. In congestive heart failure P2X<sub>1</sub> receptors are downregulated in VSMC in resistance arteries, which could represent a protective response against the increased sympathetic nerve activity and peripheral resistance seen in congestive heart failure [<xref ref-type="bibr" rid="CR189">189</xref>].</p>
        <p>Several P2 receptors have been suggested as targets for pharmacological treatment of congestive heart failure. Overexpression of P2X<sub>4</sub> receptors has a beneficial, life-prolonging effect in a heart failure model [<xref ref-type="bibr" rid="CR190">190</xref>]. Both ATP and catecholamines are released from sympathetic nerves, acting through cAMP-stimulating receptors to mediate positive inotropic effects, stimulating the same intracellular mechanisms as adrenergic &#x3B2;-receptors. It is possible that agonists for the P2Y<sub>11</sub> receptor could be used to improve cardiac output in patients with circulatory shock. However, an even more important drug candidate would be a P2Y<sub>11</sub> receptor antagonist that may be beneficial in patients with congestive heart failure. The extracellular pyrimidines UTP and UDP may be inotropic factors in man, acting on P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors stimulating the same intracellular pathways as angiotensin II. Synthetic agonists could thus be used as inotropic agents during circulatory shock and antagonists may have effects similar to angiotensin II receptor blockers, being beneficial in the treatment of hypertension and congestive heart failure.</p>
      </sec>
      <sec id="Sec22">
        <title>Chronotropy and arrhythmia</title>
        <p>It has been difficult to determine the chronotropic effects of ATP due to the dominating inhibitory effects of adenosine on the AV node. We know that ATP increases the contractile rate in neuron-myocyte co-cultures but the effect is markedly reduced in non-innervated myocyte cultures [<xref ref-type="bibr" rid="CR191">191</xref>]. ATP could induce arrhythmia based on its increased automaticity and early after-depolarisations [<xref ref-type="bibr" rid="CR60">60</xref>]. The P2X<sub>1</sub> receptor is colocalised with connexin 43 in gap junctions that transmit the contractile stimulus between cardiomyocytes [<xref ref-type="bibr" rid="CR192">192</xref>]. However, so far no firm evidence exists of an important role for P2 receptors for chronotropy or arrhythmia.</p>
      </sec>
    </sec>
    <sec id="Sec23">
      <title>Platelets and coagulation</title>
      <sec id="Sec24">
        <title>Platelets</title>
        <p>ADP, released from erythrocytes or produced after ectonucleotidase breakdown of ATP released from erythrocytes and endothelial cells, was found to cause platelet aggregation as early as 1961, before the concept of P2 receptors was conceived [<xref ref-type="bibr" rid="CR193">193</xref>]. Later, the effects were attributed to a single receptor, designated P2T, but it was not until 1998 that the three receptors involved were characterised [<xref ref-type="bibr" rid="CR194">194</xref>&#x2013;<xref ref-type="bibr" rid="CR196">196</xref>]. Two ADP receptors (P2Y<sub>12</sub> and P2Y<sub>1</sub>) and one ion channel ATP receptor (P2X<sub>1</sub>) are expressed on platelets [<xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR198">198</xref>] (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). The P2Y<sub>12</sub> receptor is coupled to inhibition of cAMP. The molecular identifications of the P2Y<sub>12</sub> receptor and generation of knockout mice revealed highly prolonged bleeding times, and their platelets aggregate poorly in response to ADP and display a reduced sensitivity to thrombin and collagen [<xref ref-type="bibr" rid="CR199">199</xref>]. The P2Y<sub>1</sub> receptor is responsible for ADP-induced shape change and weak, transient aggregation [<xref ref-type="bibr" rid="CR200">200</xref>&#x2013;<xref ref-type="bibr" rid="CR202">202</xref>], while the P2Y<sub>12</sub> receptor is responsible for the completion and amplification of the response to ADP and to all platelet agonists, including thromboxane A<sub>2</sub>, thrombin and collagen. The platelets also express P2Y<sub>1</sub> receptors that have been shown in knockout mice to be of similar importance as P2Y<sub>12</sub> receptors [<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR203">203</xref>].
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>P2 receptor-mediated regulation of coagulation and platelet aggregation. See text for details. ADP is an important mediator and positive feedback mechanism for platelet aggregation. Activated platelets stimulate coagulation, i.e. formation of a fibrin network. In contrast, ATP, ADP and UTP release tissue plasminogen activator (<italic>t-PA</italic>) from endothelial cells, resulting in degradation of the fibrin network. At the same time plasminogen activator inhibitor (<italic>PAI-1</italic>) is also released from endothelial cells by ATP stimulation, in turn inhibiting t-PA. Thus, P2 receptors regulate several balancing factors in haemostasis. <italic>Ado</italic> adenosine</p></caption><graphic position="anchor" xlink:href="11302_2007_9078_Fig4_HTML" id="MO4"/></fig></p>
        <p>The physiological importance of the P2X<sub>1</sub> receptor is not fully elucidated. However, recent studies have demonstrated that P2X<sub>1</sub> receptors can generate significant functional platelet responses, independently and in synergy with other receptor pathways. In addition, studies in transgenic animals indicate an important role for P2X<sub>1</sub> receptors in platelet activation, particularly under conditions of shear stress and thus during arterial thrombosis [<xref ref-type="bibr" rid="CR204">204</xref>]. Synergistic interaction between ATP and NA in stimulating platelet aggregation may have significant clinical implications and suggests a prothrombotic role for ATP in stress [<xref ref-type="bibr" rid="CR205">205</xref>].</p>
        <p>NTPDase1 is an important inhibitor of platelet activation. Unexpectedly, NTPDase1-deficient mice had prolonged bleeding times with minimally perturbed coagulation parameters. Platelet interactions with injured mesenteric vasculature were considerably reduced in vivo and purified mutant platelets failed to aggregate to standard agonists in vitro [<xref ref-type="bibr" rid="CR206">206</xref>]. This platelet hypofunction was reversible and associated with P2Y<sub>1</sub> receptor desensitisation. In keeping with deficient vascular protective mechanisms, fibrin deposition was found at multiple organ sites in NTPDase1-deficient mice and in transplanted cardiac grafts. Endothelial ADPase activity is lost following ischaemia-reperfusion injury, xenograft rejection and inflammation resulting in increased levels of ATP and ADP [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]. This may cause platelet aggregation but also other effects, such as mitogenic effects on VSMC. Infusion of systemic apyrase inhibits platelet aggregation and prolongs xenograft survival [<xref ref-type="bibr" rid="CR208">208</xref>]. This has also been shown with adenoviral transfer of NTPDase1 [<xref ref-type="bibr" rid="CR209">209</xref>]. NTPDase1 is also lost in vascular cardiac grafts subjected to oxidant stress. NTPDase2 only degrades ATP to ADP and has a prothrombotic effect. It is present in the subendothelium and can shift the balance in a prothrombotic direction after endothelial injury [<xref ref-type="bibr" rid="CR210">210</xref>] (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).</p>
        <p>ADP acting on P2Y<sub>12</sub> receptors is not only important for platelet activation, it also stimulates vasoconstriction. Stable drugs with antagonistic effects on P2Y<sub>12</sub> receptors, affecting both platelets and VSMC, could be of double therapeutic benefit in their prevention of both thrombosis and vasospasm [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
      </sec>
      <sec id="Sec25">
        <title>Coagulation</title>
        <p>The prothrombotic effect of ADP on the platelets is counteracted by the effects of UTP and ATP on the endothelium that stimulates a substantial release of tissue-type plasminogen activator (tPA) with fibrinolytic effects [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR211">211</xref>] (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). To make the picture even more complex, ATP also releases plasminogen activator inhibitor (PAI-1) which in turn inhibits tPA [<xref ref-type="bibr" rid="CR212">212</xref>]. Thus, P2 receptors are involved at several stages of haemostasis, which is important for the development of atherosclerosis and thrombotic occlusions leading to myocardial infarction and stroke.</p>
      </sec>
      <sec id="Sec26">
        <title>Clinical importance of P2 receptor-mediated regulation of platelets</title>
        <p>The first ADP inhibitors, ticlopidine and clopidogrel, were developed before the cloning and identification of the platelet ADP receptors. Later, it was concluded that they were prodrugs, converted in the liver to a metabolite that binds irreversibly to the P2Y<sub>12</sub> receptor resulting in non-competitive antagonism.</p>
        <p>Ticlodipine has the disadvantage of a small risk of neutropaenia, so that clinically so far the most important contribution of drug development aimed at P2 receptors has been the beneficial effects of the platelet ADP receptor antagonist clopidogrel in atherosclerotic disease. In the CAPRIE trial, clopidogrel was even more effective compared to aspirin in preventing myocardial infarctions [<xref ref-type="bibr" rid="CR213">213</xref>]. Clopidogrel, as an addition to aspirin, turned out to be necessary to prevent acute in-stent thrombosis in percutaneous coronary interventions. The CURE trial demonstrated that the addition of clopidogrel to aspirin reduced clinical events by 20% in acute coronary syndromes [<xref ref-type="bibr" rid="CR213">213</xref>, <xref ref-type="bibr" rid="CR214">214</xref>]. This has also been shown for ST-elevation myocardial infarctions (COMMIT, CLARITY). However, long-term secondary prevention in high-risk groups with clopidogrel added to aspirin did not have significant benefits (CHARISMA). Clopidogrel combined with aspirin reduces cerebral emboli in patients undergoing carotid endarterectomy [<xref ref-type="bibr" rid="CR215">215</xref>]. Clopidogrel (Plavix&#xAE;) is now a blockbuster drug and one of the most sold drugs worldwide to the benefit of atherosclerotic patients. Nevertheless, clopidogrel is a rather weak antagonist at P2Y<sub>12</sub> receptors with variable effects, often referred to as clopidogrel resistance. Newer P2Y<sub>12</sub> receptor antagonists, such as prasugrel and AZD6140, have a stronger more consistent effect and are currently being studied in major clinical trials (TRITON and PLATO).</p>
      </sec>
    </sec>
    <sec id="Sec27">
      <title>Clinical importance of purinergic signalling in cardiovascular disease: future directions</title>
      <p>The P2 receptor family provides opportunities for drug development (see Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>). The large number of receptor subtypes and the increasing knowledge of their tissue distributions may make it possible to target a specific cardiovascular organ with limited side effects. So far, only P2Y<sub>12</sub> receptor antagonists have been explored in patients, but with extraordinary success. Clopidogrel is one of the most prescribed drugs in the world for the treatment of thrombosis, stroke and myocardial infarctions in millions of patients. The following compounds, prasugrel and AZD6140, are even more potent P2Y<sub>12</sub> receptor antagonists with clinical benefits currently being tested in phase III trials. Improved platelet inhibition can also be achieved with antagonists against the other two P2 receptors on platelets. Studies in P2Y<sub>1</sub> and P2X<sub>1</sub> receptor knockout mice and experimental thrombosis models using selective P2Y<sub>1</sub> and P2X<sub>1</sub> receptor antagonists have shown that, depending on the conditions, these receptors could also be potential targets for new antithrombotic drugs.
<table-wrap id="Tab4"><label>Table&#xA0;4</label><caption><p>Cardiovascular disease targets</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Receptor target</th><th>Agonist/antagonist activity of therapeutic drug</th><th>Disease</th></tr></thead><tbody><tr><td colspan="3">Vascular smooth muscle cell</td></tr><tr><td>P2Y<sub>2</sub></td><td>Antagonist</td><td>Hypertension, restenosis, diabetic microvascular disease, subarachnoidal bleeding</td></tr><tr><td>P2Y<sub>6</sub></td><td>Antagonist</td><td>Hypertension, restenosis, diabetic microvascular disease, subarachnoidal bleeding</td></tr><tr><td>P2Y<sub>12</sub></td><td>Antagonist</td><td>Hypertension, vasospasm</td></tr><tr><td>P2X<sub>1</sub></td><td>Antagonist</td><td>Hypertension, migraine, subarachnoidal bleeding</td></tr><tr><td>P2Y<sub>6</sub></td><td>Agonist</td><td>Migraine</td></tr><tr><td>SolNTPDase1</td><td>Ectonucleotidase</td><td>Restenosis, xenograft rejection</td></tr><tr><td colspan="3">Endothelial cell</td></tr><tr><td>P2Y<sub>2</sub></td><td>Antagonist</td><td>Atherosclerosis, inflammation</td></tr><tr><td>P2X<sub>4</sub></td><td>Antagonist</td><td>Vascular remodelling (cancer?), preeclampsia</td></tr><tr><td colspan="3">Heart</td></tr><tr><td>P2Y<sub>2</sub></td><td>Antagonist</td><td>Congestive heart failure</td></tr><tr><td>P2Y<sub>6</sub></td><td>Antagonist</td><td>Congestive heart failure</td></tr><tr><td>P2Y<sub>11</sub></td><td>Antagonist</td><td>Congestive heart failure, myocardial infarction</td></tr><tr><td>P2Y<sub>2</sub></td><td>Agonist</td><td>Shock, reduced cardiac output, cardiac protection</td></tr><tr><td>P2Y<sub>6</sub></td><td>Agonist</td><td>Shock, reduced cardiac output</td></tr><tr><td>P2Y<sub>11</sub></td><td>Agonist</td><td>Shock, reduced cardiac output</td></tr><tr><td>SolNTPDase1</td><td>Ectonucleotidase</td><td>Heart transplantation, myocardial infarction</td></tr><tr><td colspan="3">Inflammatory cells</td></tr><tr><td>P2Y<sub>2</sub></td><td>Antagonist</td><td>Atherosclerosis</td></tr><tr><td>P2Y<sub>11</sub></td><td>Antagonist</td><td>Atherosclerosis</td></tr><tr><td>P2X<sub>7</sub></td><td>Antagonist</td><td>Atherosclerosis</td></tr><tr><td colspan="3">Platelets</td></tr><tr><td>P2Y<sub>1</sub></td><td>Antagonist</td><td>Myocardial infarction, stroke, peripheral artery disease</td></tr><tr><td>P2Y<sub>12</sub></td><td>Antagonist</td><td>Myocardial infarction, stroke, peripheral artery disease</td></tr><tr><td>P2X<sub>1</sub></td><td>Antagonist</td><td>Myocardial infarction, stroke, peripheral artery disease</td></tr><tr><td>SolNTPDase1</td><td>Ectonucleotidase</td><td>Myocardial infarction, stroke, peripheral artery disease</td></tr><tr><td colspan="3">Red blood cell</td></tr><tr><td>P2Y<sub>13</sub></td><td>Antagonist</td><td>Improved peripheral circulation</td></tr><tr><td>P2X<sub>7</sub></td><td>Antagonist</td><td>Shock</td></tr><tr><td colspan="3">Perivascular nociceptive sensory nerves</td></tr><tr><td>P2Y<sub>1</sub></td><td>Agonist</td><td>Migraine, vascular pain</td></tr><tr><td>P2X<sub>3</sub></td><td>Antagonist</td><td>Migraine, vascular pain</td></tr><tr><td colspan="3">Perivascular sympathetic nerves</td></tr><tr><td>P2Y<sub>1</sub></td><td>Agonist</td><td>Hypertension</td></tr><tr><td>P2X<sub>2</sub></td><td>Antagonist</td><td>Hypertension</td></tr></tbody></table><table-wrap-foot><p>The table presents possible targets for the development of new pharmaceutical compounds for the treatment of cardiovascular diseases</p></table-wrap-foot></table-wrap></p>
      <p>ATP, UTP and UDP, acting on P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors, are potent stimulators of inflammation, VSMC proliferation and migration. Antagonists to these receptors may be explored to protect against atherosclerosis, restenosis after balloon angioplasty, chronic transplant rejection and diabetic microvascular disease.</p>
      <p>It is possible that hypertension and pulmonary hypertension could be treated with P2X<sub>1</sub>, P2Y<sub>2</sub>, P2Y<sub>6</sub> or P2Y<sub>12</sub> receptor antagonists. In the heart P2Y<sub>2</sub>, P2Y<sub>6</sub> and P2Y<sub>11</sub> receptor antagonists may have similar beneficial roles as angiotensin inhibition or &#x3B2;-blockers in the treatment of congestive heart failure. In the acute phase of a myocardial infarction, a UTP analogue could protect cardiomyocytes and limit infarct size. A polymorphism in P2Y<sub>11</sub> receptors could be considered as a prognostic marker to identify patients at risk of myocardial infarction and drugs aimed at the receptor could be explored to prevent myocardial infarction.</p>
      <p>A promising strategy would be to use soluble NTPDase to prevent thrombosis, restenosis and xenograft transplantation. SolNTPDase1 protects against brain damage in a stroke model and a human genetically engineered solNTPDase has been developed that could be used in clinical trials. Possible clinical indications could be stroke, myocardial infarction and transplantation. P2X<sub>3</sub> receptor antagonists could be used against migraine and vascular pain [see <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drury</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Szent-Gy&#xF6;rgyi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The physiological activity of adenine compounds with special reference to their action upon the mammalian heart</article-title>
          <source>J Physiol</source>
          <year>1929</year>
          <volume>68</volume>
          <fpage>213</fpage>
          <lpage>237</lpage>
        </citation>
        <citation citation-type="display-unstructured">Drury A, Szent-Gy&#xF6;rgyi A (1929) The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68:213&#x2013;237 <pub-id pub-id-type="pmid">16994064</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Straub</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>A basis for distinguishing two types of purinergic receptor</article-title>
          <source>Cell membrane receptors for drugs and hormones: a multidisciplinary approach</source>
          <year>1978</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Raven</publisher-name>
          <fpage>107</fpage>
          <lpage>118</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW (ed) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven, New York, pp 107&#x2013;118 </citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Purinergic nerves</article-title>
          <source>Pharmacol Rev</source>
          <year>1972</year>
          <volume>24</volume>
          <fpage>509</fpage>
          <lpage>581</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509&#x2013;581 <pub-id pub-id-type="pmid">4404211</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The past, present and future of purine nucleotides as signalling molecules</article-title>
          <source>Neuropharmacology</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>1127</fpage>
          <lpage>1139</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127&#x2013;1139 <pub-id pub-id-type="pmid">9364468</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ralevic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Receptors for purines and pyrimidines</article-title>
          <source>Pharmacol Rev</source>
          <year>1998</year>
          <volume>50</volume>
          <fpage>413</fpage>
          <lpage>492</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413&#x2013;492 <pub-id pub-id-type="pmid">9755289</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Physiology and pathophysiology of purinergic neurotransmission</article-title>
          <source>Physiol Rev</source>
          <year>2007</year>
          <volume>87</volume>
          <fpage>659</fpage>
          <lpage>797</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659&#x2013;797 <pub-id pub-id-type="pmid">17429044</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Extracellular ATP: effects, sources and fate</article-title>
          <source>Biochem J</source>
          <year>1986</year>
          <volume>233</volume>
          <fpage>309</fpage>
          <lpage>319</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309&#x2013;319 <pub-id pub-id-type="pmid">3006665</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Ectonucleotidases in the nervous system</article-title>
          <source>Novartis Found Symp</source>
          <year>2006</year>
          <volume>276</volume>
          <fpage>113</fpage>
          <lpage>128</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113&#x2013;128 <pub-id pub-id-type="pmid">16805426</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A dual function for adenosine 5&#x2032;-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent</article-title>
          <source>Circ Res</source>
          <year>1986</year>
          <volume>58</volume>
          <fpage>319</fpage>
          <lpage>330</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G, Kennedy C (1986) A dual function for adenosine 5&#x2019;-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58:319&#x2013;330 <pub-id pub-id-type="pmid">3013455</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular purinoceptors</article-title>
          <source>Physiol Rev</source>
          <year>1990</year>
          <volume>70</volume>
          <fpage>761</fpage>
          <lpage>845</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70:761&#x2013;845 <pub-id pub-id-type="pmid">2194223</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ralevic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Roles of P2-purinoceptors in the cardiovascular system</article-title>
          <source>Circulation</source>
          <year>1991</year>
          <volume>84</volume>
          <fpage>1</fpage>
          <lpage>14</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ralevic V, Burnstock G (1991) Roles of P2-purinoceptors in the cardiovascular system. Circulation 84:1&#x2013;14 <pub-id pub-id-type="pmid">1647896</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Extracellular ATP: a growth factor for vascular smooth muscle cells</article-title>
          <source>Gen Pharmacol</source>
          <year>1998</year>
          <volume>31</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D (1998) Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31:1&#x2013;8 <pub-id pub-id-type="pmid">9595270</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Purinergic signalling and vascular cell proliferation and death</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>364</fpage>
          <lpage>373</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2002) Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364&#x2013;373 <pub-id pub-id-type="pmid">11884276</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Virgilio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Solini</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>P2 receptors: new potential players in atherosclerosis</article-title>
          <source>Br J Pharmacol</source>
          <year>2002</year>
          <volume>135</volume>
          <fpage>831</fpage>
          <lpage>842</lpage>
        </citation>
        <citation citation-type="display-unstructured">Di Virgilio F, Solini A (2002) P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135:831&#x2013;842 <pub-id pub-id-type="pmid">11861311</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gachet</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Regulation of platelet functions by P2 receptors</article-title>
          <source>Annu Rev Pharmacol Toxicol</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>277</fpage>
          <lpage>300</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277&#x2013;300 <pub-id pub-id-type="pmid">16402906</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agteresch</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Dagnelie</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Berg</surname>
              <given-names>JW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine triphosphate: established and potential clinical applications</article-title>
          <source>Drugs</source>
          <year>1999</year>
          <volume>58</volume>
          <fpage>211</fpage>
          <lpage>232</lpage>
        </citation>
        <citation citation-type="display-unstructured">Agteresch HJ, Dagnelie PC, van den Berg JW et al (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211&#x2013;232 <pub-id pub-id-type="pmid">10473017</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ralevic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Involvement of purinergic signaling in cardiovascular diseases</article-title>
          <source>Drug News Perspect</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>133</fpage>
          <lpage>140</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ralevic V, Burnstock G (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16:133&#x2013;140 <pub-id pub-id-type="pmid">12819811</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atkinson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Enjyoji</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>217</fpage>
          <lpage>222</lpage>
        </citation>
        <citation citation-type="display-unstructured">Atkinson B, Dwyer K, Enjyoji K et al (2006) Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol Dis 36:217&#x2013;222 <pub-id pub-id-type="pmid">16476557</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pathophysiology and therapeutic potential of purinergic signaling</article-title>
          <source>Pharmacol Rev</source>
          <year>2006</year>
          <volume>58</volume>
          <fpage>58</fpage>
          <lpage>86</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58&#x2013;86 <pub-id pub-id-type="pmid">16507883</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Do some nerve cells release more than one transmitter?</article-title>
          <source>Neuroscience</source>
          <year>1976</year>
          <volume>1</volume>
          <fpage>239</fpage>
          <lpage>248</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1976) Do some nerve cells release more than one transmitter? Neuroscience 1:239&#x2013;248 <pub-id pub-id-type="pmid">11370511</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Sympathetic purinergic transmission in small blood vessels</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1988</year>
          <volume>9</volume>
          <fpage>116</fpage>
          <lpage>117</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1988) Sympathetic purinergic transmission in small blood vessels. Trends Pharmacol Sci 9:116&#x2013;117 <pub-id pub-id-type="pmid">2907697</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Local control of blood pressure by purines</article-title>
          <source>Blood Vessels</source>
          <year>1987</year>
          <volume>24</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1987) Local control of blood pressure by purines. Blood Vessels 24:156&#x2013;160 <pub-id pub-id-type="pmid">3036284</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Vanhoutte</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Local purinergic regulation of blood pressure (The First John T. Shepherd Lecture)</article-title>
          <source>Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium</source>
          <year>1988</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Raven</publisher-name>
          <fpage>1</fpage>
          <lpage>14</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1988) Local purinergic regulation of blood pressure (The First John T. Shepherd Lecture). In: Vanhoutte PM (ed) Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. Raven, New York, pp 1&#x2013;14 </citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Local mechanisms of blood flow control by perivascular nerves and endothelium</article-title>
          <source>J Hypertens Suppl</source>
          <year>1990</year>
          <volume>8</volume>
          <fpage>S95</fpage>
          <lpage>S106</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1990) Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl 8:S95&#x2013;S106 <pub-id pub-id-type="pmid">1982771</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Noradrenaline and ATP as cotransmitters in sympathetic nerves</article-title>
          <source>Neurochem Int</source>
          <year>1990</year>
          <volume>17</volume>
          <fpage>357</fpage>
          <lpage>368</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1990) Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 17:357&#x2013;368 </citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A unifying purinergic hypothesis for the initiation of pain</article-title>
          <source>Lancet</source>
          <year>1996</year>
          <volume>347</volume>
          <fpage>1604</fpage>
          <lpage>1605</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1996) A unifying purinergic hypothesis for the initiation of pain. Lancet 347:1604&#x2013;1605 <pub-id pub-id-type="pmid">8667873</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Uddman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Introduction: changing face of autonomic and sensory nerves in the circulation</article-title>
          <source>Vascular innervation and receptor mechanisms: new perspectives</source>
          <year>1993</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Academic</publisher-name>
          <fpage>1</fpage>
          <lpage>22</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1993) Introduction: changing face of autonomic and sensory nerves in the circulation. In: Edvinsson L, Uddman R (eds) Vascular innervation and receptor mechanisms: new perspectives. Academic, New York, pp 1&#x2013;22 </citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function</article-title>
          <source>Cardiovasc Res</source>
          <year>1996</year>
          <volume>31</volume>
          <fpage>467</fpage>
          <lpage>479</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rubino A, Burnstock G (1996) Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 31:467&#x2013;479 <pub-id pub-id-type="pmid">8689638</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vial</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>P2X<sub>1</sub> receptor-deficient mice establish the native P2X receptor and a P2Y<sub>6</sub>-like receptor in arteries</article-title>
          <source>Mol Pharmacol</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>1438</fpage>
          <lpage>1445</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438&#x2013;1445 <pub-id pub-id-type="pmid">12435812</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramme</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Regenold</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Starke</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1987</year>
          <volume>336</volume>
          <fpage>267</fpage>
          <lpage>273</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ramme D, Regenold JT, Starke K et al (1987) Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 336:267&#x2013;273 <pub-id pub-id-type="pmid">2891041</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Unwin</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bardini</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Localization of P2X<sub>1</sub> purinoceptors by autoradiography and immunohistochemistry in rat kidneys</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>274</volume>
          <fpage>F799</fpage>
          <lpage>F804</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chan CM, Unwin RJ, Bardini M et al (1998) Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274:F799&#x2013;F804 <pub-id pub-id-type="pmid">9575906</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inscho</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Imig</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Renal autoregulation in P2X<sub>1</sub> knockout mice</article-title>
          <source>Acta Physiol Scand</source>
          <year>2004</year>
          <volume>181</volume>
          <fpage>445</fpage>
          <lpage>453</lpage>
        </citation>
        <citation citation-type="display-unstructured">Inscho EW, Cook AK, Imig JD et al (2004) Renal autoregulation in P2X1 knockout mice. Acta Physiol Scand 181:445&#x2013;453 <pub-id pub-id-type="pmid">15283757</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inscho</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Imig</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Physiological role for P2X<sub>1</sub> receptors in renal microvascular autoregulatory behavior</article-title>
          <source>J Clin Invest</source>
          <year>2003</year>
          <volume>112</volume>
          <fpage>1895</fpage>
          <lpage>1905</lpage>
        </citation>
        <citation citation-type="display-unstructured">Inscho EW, Cook AK, Imig JD et al (2003) Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112:1895&#x2013;1905 <pub-id pub-id-type="pmid">14679185</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boehm</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huck</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Receptors controlling transmitter release from sympathetic neurons in vitro</article-title>
          <source>Prog Neurobiol</source>
          <year>1997</year>
          <volume>51</volume>
          <fpage>225</fpage>
          <lpage>242</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boehm S, Huck S (1997) Receptors controlling transmitter release from sympathetic neurons in vitro. Prog Neurobiol 51:225&#x2013;242 <pub-id pub-id-type="pmid">9089789</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors</article-title>
          <source>Neurochem Int</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>107</fpage>
          <lpage>125</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha R (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38:107&#x2013;125 <pub-id pub-id-type="pmid">11137880</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Todorov</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Mihaylova-Todorova</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Westfall</surname>
              <given-names>TD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>387</volume>
          <fpage>76</fpage>
          <lpage>79</lpage>
        </citation>
        <citation citation-type="display-unstructured">Todorov LD, Mihaylova-Todorova S, Westfall TD et al (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76&#x2013;79 <pub-id pub-id-type="pmid">9139824</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenmeier</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gonzalez-Alonso</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle</article-title>
          <source>J Physiol</source>
          <year>2004</year>
          <volume>558</volume>
          <fpage>351</fpage>
          <lpage>365</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rosenmeier JB, Hansen J, Gonzalez-Alonso J (2004) Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558:351&#x2013;365 <pub-id pub-id-type="pmid">15155791</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Is there a basis for distinguishing two types of P2-purinoceptor?</article-title>
          <source>Gen Pharmacol</source>
          <year>1985</year>
          <volume>16</volume>
          <fpage>433</fpage>
          <lpage>440</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433&#x2013;440 <pub-id pub-id-type="pmid">2996968</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries</article-title>
          <source>J Auton Nerv Syst</source>
          <year>2000</year>
          <volume>81</volume>
          <fpage>69</fpage>
          <lpage>74</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lewis CJ, Evans RJ (2000) Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries. J Auton Nerv Syst 81:69&#x2013;74 <pub-id pub-id-type="pmid">10869703</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2 receptor expression profiles in human vascular smooth muscle and endothelial cells</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>841</fpage>
          <lpage>853</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang L, Karlsson L, Moses S et al (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40:841&#x2013;853 <pub-id pub-id-type="pmid">12451317</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xFC;gelgen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Haussinger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Starke</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1987</year>
          <volume>336</volume>
          <fpage>556</fpage>
          <lpage>560</lpage>
        </citation>
        <citation citation-type="display-unstructured">von K&#xFC;gelgen I, Haussinger D, Starke K (1987) Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol 336:556&#x2013;560 <pub-id pub-id-type="pmid">3437923</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The stable pyrimidines UDP&#x3B2;S and UTP&#x3B3;S discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery</article-title>
          <source>Br J Pharmacol</source>
          <year>2000</year>
          <volume>131</volume>
          <fpage>51</fpage>
          <lpage>56</lpage>
        </citation>
        <citation citation-type="display-unstructured">Malmsj&#xF6; M, Adner M, Harden TK et al (2000) The stable pyrimidines UDP&#x3B2;S and UTP&#x3B3;S discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol 131:51&#x2013;56 <pub-id pub-id-type="pmid">10960068</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="other">S&#xE9;vigny J et al (2006) Co-ordinated regulation of P2-receptor signaling by membrane bound NTPDases. Purinergic Signalling 2:53</citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borna</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gudbjartsson</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contractions in human coronary bypass vessels stimulated by extracellular nucleotides</article-title>
          <source>Ann Thorac Surg</source>
          <year>2003</year>
          <volume>76</volume>
          <fpage>50</fpage>
          <lpage>57</lpage>
        </citation>
        <citation citation-type="display-unstructured">Borna C, Wang L, Gudbjartsson T et al (2003) Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg 76:50&#x2013;57 <pub-id pub-id-type="pmid">12842512</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinson</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <article-title>Differential regulation of the uridine nucleotide-activated P2Y<sub>4</sub> and P2Y<sub>6</sub> receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y<sub>4</sub> receptor</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>11939</fpage>
          <lpage>11948</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276:11939&#x2013;11948 <pub-id pub-id-type="pmid">11114308</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wihlborg</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>OO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ADP receptor P2Y<sub>12</sub> is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1810</fpage>
          <lpage>1815</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wihlborg AK, Wang L, Braun OO et al (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24:1810&#x2013;1815 <pub-id pub-id-type="pmid">15308557</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction</article-title>
          <source>J Anat</source>
          <year>1999</year>
          <volume>194</volume>
          <fpage>335</fpage>
          <lpage>342</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335&#x2013;342 <pub-id pub-id-type="pmid">10386771</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation</article-title>
          <source>Br J Pharmacol</source>
          <year>1998</year>
          <volume>123</volume>
          <fpage>719</fpage>
          <lpage>729</lpage>
        </citation>
        <citation citation-type="display-unstructured">Malmsj&#xF6; M, Edvinsson L, Erlinge D (1998) P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation. Br J Pharmacol 123:719&#x2013;729 <pub-id pub-id-type="pmid">9517392</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>H&#xF6;gest&#xE4;tt</surname>
              <given-names>ED</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor</article-title>
          <source>Eur J Pharmacol</source>
          <year>1999</year>
          <volume>364</volume>
          <fpage>169</fpage>
          <lpage>173</lpage>
        </citation>
        <citation citation-type="display-unstructured">Malmsj&#xF6; M, Erlinge D, H&#xF6;gest&#xE4;tt ED et al (1999) Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor. Eur J Pharmacol 364:169&#x2013;173 <pub-id pub-id-type="pmid">9932720</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mistry</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gitlin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric artery</article-title>
          <source>Br J Pharmacol</source>
          <year>2003</year>
          <volume>139</volume>
          <fpage>661</fpage>
          <lpage>671</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mistry H, Gitlin JM, Mitchell JA et al (2003) Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric artery. Br J Pharmacol 139:661&#x2013;671 <pub-id pub-id-type="pmid">12788826</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hrafnkelsdottir</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jern</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man</article-title>
          <source>Thromb Haemost</source>
          <year>2001</year>
          <volume>85</volume>
          <fpage>875</fpage>
          <lpage>881</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hrafnkelsdottir T, Erlinge D, Jern S (2001) Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thromb Haemost 85:875&#x2013;881 <pub-id pub-id-type="pmid">11372682</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wihlborg</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eyjolfsson</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor</article-title>
          <source>Br J Pharmacol</source>
          <year>2003</year>
          <volume>138</volume>
          <fpage>1451</fpage>
          <lpage>1458</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wihlborg AK, Malmsj&#xF6; M, Eyjolfsson A et al (2003) Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br J Pharmacol 138:1451&#x2013;1458 <pub-id pub-id-type="pmid">12721100</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guns</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Korda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crauwels</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta</article-title>
          <source>Br J Pharmacol</source>
          <year>2005</year>
          <volume>146</volume>
          <fpage>288</fpage>
          <lpage>295</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guns PJ, Korda A, Crauwels HM et al (2005) Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol 146:288&#x2013;295 <pub-id pub-id-type="pmid">15997227</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Korenaga</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kamiya</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X<sub>4</sub> receptors mediate ATP-induced calcium influx in human vascular endothelial cells</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2000</year>
          <volume>279</volume>
          <fpage>H285</fpage>
          <lpage>H292</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yamamoto K, Korenaga R, Kamiya A et al (2000) P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 279:H285&#x2013;H292 <pub-id pub-id-type="pmid">10899068</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Korenaga</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kamiya</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fluid shear stress activates Ca<sup>2+</sup> influx into human endothelial cells via P2X<sub>4</sub> purinoceptors</article-title>
          <source>Circ Res</source>
          <year>2000</year>
          <volume>87</volume>
          <fpage>385</fpage>
          <lpage>391</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yamamoto K, Korenaga R, Kamiya A et al (2000) Fluid shear stress activates Ca2+ influx into human endothelial cells via P2X4 purinoceptors. Circ Res 87:385&#x2013;391 <pub-id pub-id-type="pmid">10969036</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bodin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells</article-title>
          <source>Br J Pharmacol</source>
          <year>1991</year>
          <volume>103</volume>
          <fpage>1203</fpage>
          <lpage>1205</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bodin P, Bailey D, Burnstock G (1991) Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 103:1203&#x2013;1205 <pub-id pub-id-type="pmid">1652343</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sokabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired flow-dependent control of vascular tone and remodeling in P2X<sub>4</sub>-deficient mice</article-title>
          <source>Nat Med</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>133</fpage>
          <lpage>137</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yamamoto K, Sokabe T, Matsumoto T et al (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12:133&#x2013;137 <pub-id pub-id-type="pmid">16327800</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaczmarek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Koziak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>S&#xE9;vigny</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification and characterization of CD39/vascular ATP diphosphohydrolase</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>33116</fpage>
          <lpage>33122</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaczmarek E, Koziak K, S&#xE9;vigny J et al (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271:33116&#x2013;33122 <pub-id pub-id-type="pmid">8955160</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yegutkin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bodin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5&#x2019;-nucleotidase along with endogenous ATP from vascular endothelial cells</article-title>
          <source>Br J Pharmacol</source>
          <year>2000</year>
          <volume>129</volume>
          <fpage>921</fpage>
          <lpage>926</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yegutkin G, Bodin P, Burnstock G (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5&#x2019;-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129:921&#x2013;926 <pub-id pub-id-type="pmid">10696091</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vassort</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Adenosine 5&#x2019;-triphosphate: a P2-purinergic agonist in the myocardium</article-title>
          <source>Physiol Rev</source>
          <year>2001</year>
          <volume>81</volume>
          <fpage>767</fpage>
          <lpage>806</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vassort G (2001) Adenosine 5&#x2019;-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767&#x2013;806 <pub-id pub-id-type="pmid">11274344</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Steinhart</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Nixon</surname>
              <given-names>DC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia</article-title>
          <source>Circ Res</source>
          <year>1981</year>
          <volume>49</volume>
          <fpage>1262</fpage>
          <lpage>1267</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saito D, Steinhart CR, Nixon DC et al (1981) Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ Res 49:1262&#x2013;1267 <pub-id pub-id-type="pmid">7307243</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zatta</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Headrick</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Mediators of coronary reactive hyperaemia in isolated mouse heart</article-title>
          <source>Br J Pharmacol</source>
          <year>2005</year>
          <volume>144</volume>
          <fpage>576</fpage>
          <lpage>587</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zatta AJ, Headrick JP (2005) Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol 144:576&#x2013;587 <pub-id pub-id-type="pmid">15655499</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olivecrona</surname>
              <given-names>GK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary artery reperfusion: the ADP receptor P2Y<sub>1</sub> mediates early reactive hyperemia in vivo in pigs</article-title>
          <source>Purinergic Signalling</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>59</fpage>
          <lpage>64</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olivecrona GK et al (2006) Coronary artery reperfusion: the ADP receptor P2Y1 mediates early reactive hyperemia in vivo in pigs. Purinergic Signalling 1:59&#x2013;64 </citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellsworth</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>CG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The erythrocyte as a regulator of vascular tone</article-title>
          <source>Am J Physiol</source>
          <year>1995</year>
          <volume>269</volume>
          <fpage>H2155</fpage>
          <lpage>H2161</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ellsworth ML, Forrester T, Ellis CG et al (1995) The erythrocyte as a regulator of vascular tone. Am J Physiol 269:H2155&#x2013;H2161 <pub-id pub-id-type="pmid">8594927</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMahon</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Luschinger</surname>
              <given-names>BP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitric oxide in the human respiratory cycle</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>711</fpage>
          <lpage>717</lpage>
        </citation>
        <citation citation-type="display-unstructured">McMahon TJ, Moon RE, Luschinger BP et al (2002) Nitric oxide in the human respiratory cycle. Nat Med 8:711&#x2013;717 <pub-id pub-id-type="pmid">12042776</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cosby</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Partovi</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation</article-title>
          <source>Nat Med</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>1498</fpage>
          <lpage>1505</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cosby K, Partovi KS, Crawford JH et al (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498&#x2013;1505 <pub-id pub-id-type="pmid">14595407</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergfeld</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia</article-title>
          <source>Cardiovasc Res</source>
          <year>1992</year>
          <volume>26</volume>
          <fpage>40</fpage>
          <lpage>47</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40&#x2013;47 <pub-id pub-id-type="pmid">1325292</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sprague</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2001</year>
          <volume>281</volume>
          <fpage>C1158</fpage>
          <lpage>C1164</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sprague RS (2001) Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 281:C1158&#x2013;C1164 <pub-id pub-id-type="pmid">11546651</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sprague</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Stephenson</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Ellsworth</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension</article-title>
          <source>Exp Biol Med (Maywood)</source>
          <year>2001</year>
          <volume>226</volume>
          <fpage>434</fpage>
          <lpage>439</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sprague RS, Stephenson AH, Ellsworth ML et al (2001) Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) 226:434&#x2013;439 <pub-id pub-id-type="pmid">11393171</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dietrich</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Ellsworth</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Sprague</surname>
              <given-names>RS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Red blood cell regulation of microvascular tone through adenosine triphosphate</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2000</year>
          <volume>278</volume>
          <fpage>H1294</fpage>
          <lpage>H1298</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dietrich HH, Ellsworth ML, Sprague RS et al (2000) Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 278:H1294&#x2013;H1298 <pub-id pub-id-type="pmid">10749727</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Alonso</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Saltin</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP</article-title>
          <source>Circ Res</source>
          <year>2002</year>
          <volume>91</volume>
          <fpage>1046</fpage>
          <lpage>1055</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gonzalez-Alonso J, Olsen DB, Saltin B (2002) Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 91:1046&#x2013;1055 <pub-id pub-id-type="pmid">12456491</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farias</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>MV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Plasma ATP during exercise: possible role in regulation of coronary blood flow</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2005</year>
          <volume>288</volume>
          <fpage>H1586</fpage>
          <lpage>H1590</lpage>
        </citation>
        <citation citation-type="display-unstructured">Farias M, Gorman MW, Savage MV et al (2005) Plasma ATP during exercise: possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol 288:H1586&#x2013;H1590 <pub-id pub-id-type="pmid">15563530</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Olivecrona</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>G&#xF6;tberg</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ADP acting on P2Y<sub>13</sub> receptors is a negative feedback pathway for ATP release from human red blood cells</article-title>
          <source>Circ Res</source>
          <year>2005</year>
          <volume>96</volume>
          <fpage>189</fpage>
          <lpage>196</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang L, Olivecrona G, G&#xF6;tberg M et al (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 96:189&#x2013;196 <pub-id pub-id-type="pmid">15604418</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olearczyk</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Ellsworth</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Stephenson</surname>
              <given-names>AH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitric oxide inhibits ATP release from erythrocytes</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2004</year>
          <volume>309</volume>
          <fpage>1079</fpage>
          <lpage>1084</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olearczyk JJ, Ellsworth ML, Stephenson AH et al (2004) Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther 309:1079&#x2013;1084 <pub-id pub-id-type="pmid">14766946</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trams</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Kauffman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A proposal for the role of ecto-enzymes and adenylates in traumatic shock</article-title>
          <source>J Theor Biol</source>
          <year>1980</year>
          <volume>87</volume>
          <fpage>609</fpage>
          <lpage>621</lpage>
        </citation>
        <citation citation-type="display-unstructured">Trams EJ, Kauffman H, Burnstock G (1980) A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 87:609&#x2013;621 <pub-id pub-id-type="pmid">6454030</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sluyter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shemon</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Barden</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X<sub>7</sub> receptor</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>44749</fpage>
          <lpage>44755</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sluyter R, Shemon AN, Barden JA et al (2004) Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor. J Biol Chem 279:44749&#x2013;44755 <pub-id pub-id-type="pmid">15304508</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bodin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>ATP-stimulated release of ATP by human endothelial cells</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1996</year>
          <volume>27</volume>
          <fpage>872</fpage>
          <lpage>875</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bodin P, Burnstock G (1996) ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 27:872&#x2013;875 <pub-id pub-id-type="pmid">8761855</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanneur</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Duranton</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>VB</given-names>
            </name>
          </person-group>
          <article-title>Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes</article-title>
          <source>FASEB J</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>133</fpage>
          <lpage>135</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tanneur V, Duranton C, Brand VB (2006) Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J 20:133&#x2013;135 <pub-id pub-id-type="pmid">16267125</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Locovei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pannexin 1 in erythrocytes: function without a gap</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>7655</fpage>
          <lpage>7659</lpage>
        </citation>
        <citation citation-type="display-unstructured">Locovei S, Bao L, Dahl G (2006) Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA 103:7655&#x2013;7659 <pub-id pub-id-type="pmid">16682648</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vidal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hicks</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>SZ</given-names>
            </name>
          </person-group>
          <article-title>Differential effects of &#x3B1;-&#x3B2;-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1986</year>
          <volume>332</volume>
          <fpage>384</fpage>
          <lpage>390</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vidal M, Hicks PE, Langer SZ (1986) Differential effects of &#x3B1;-&#x3B2;-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol 332:384&#x2013;390 <pub-id pub-id-type="pmid">3755503</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brock</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Helden</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats</article-title>
          <source>Pflugers Arch</source>
          <year>1995</year>
          <volume>430</volume>
          <fpage>901</fpage>
          <lpage>908</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brock JA, Van Helden DF (1995) Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch 430:901&#x2013;908 <pub-id pub-id-type="pmid">8594542</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandez</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wangensteen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Osuna</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Renal vascular reactivity to P<sub>2</sub>-purinoceptor activation in spontaneously hypertensive rats</article-title>
          <source>Pharmacology</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>47</fpage>
          <lpage>50</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fernandez O, Wangensteen R, Osuna A et al (2000) Renal vascular reactivity to P2-purinoceptor activation in spontaneously hypertensive rats. Pharmacology 60:47&#x2013;50 <pub-id pub-id-type="pmid">10629443</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galligan</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Hess</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>SB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2001</year>
          <volume>296</volume>
          <fpage>478</fpage>
          <lpage>485</lpage>
        </citation>
        <citation citation-type="display-unstructured">Galligan JJ, Hess MC, Miller SB et al (2001) Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. J Pharmacol Exp Ther 296:478&#x2013;485 <pub-id pub-id-type="pmid">11160634</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gluais</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats</article-title>
          <source>Fundam Clin Pharmacol</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>321</fpage>
          <lpage>326</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yang D, Gluais P, Zhang JN et al (2004) Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats. Fundam Clin Pharmacol 18:321&#x2013;326 <pub-id pub-id-type="pmid">15147283</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vonend</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models</article-title>
          <source>Kidney Int</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>157</fpage>
          <lpage>166</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vonend O, Turner CM, Chan CM et al (2004) Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int 66:157&#x2013;166 <pub-id pub-id-type="pmid">15200422</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schluter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Offers</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Br&#xFC;ggemann</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diadenosine phosphates and the physiological control of blood pressure</article-title>
          <source>Nature</source>
          <year>1994</year>
          <volume>367</volume>
          <fpage>186</fpage>
          <lpage>188</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schluter H, Offers E, Br&#xFC;ggemann G et al (1994) Diadenosine phosphates and the physiological control of blood pressure. Nature 367:186&#x2013;188 <pub-id pub-id-type="pmid">8114917</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hollah</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hausberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kosch</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel assay for determination of diadenosine polyphosphates in human platelets: studies in normotensive subjects and in patients with essential hypertension</article-title>
          <source>J Hypertens</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>237</fpage>
          <lpage>245</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hollah P, Hausberg M, Kosch M et al (2001) A novel assay for determination of diadenosine polyphosphates in human platelets: studies in normotensive subjects and in patients with essential hypertension. J Hypertens 19:237&#x2013;245 <pub-id pub-id-type="pmid">11212966</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jankowski</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>T&#xF6;lle</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vanholder</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor</article-title>
          <source>Nat Med</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>223</fpage>
          <lpage>227</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jankowski V, T&#xF6;lle M, Vanholder R et al (2005) Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 11:223&#x2013;227 <pub-id pub-id-type="pmid">15665829</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Brockman</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-translational modifications of the P2X<sub>4</sub> purinergic receptor subtype in the human placenta are altered in preeclampsia</article-title>
          <source>Placenta</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>270</fpage>
          <lpage>277</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roberts VH, Webster RP, Brockman DE et al (2006) Post-translational modifications of the P2X4 purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 28:270&#x2013;277 <pub-id pub-id-type="pmid">16793133</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sprague</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Olearczyk</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Spence</surname>
              <given-names>DM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2003</year>
          <volume>285</volume>
          <fpage>H693</fpage>
          <lpage>H700</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sprague RS, Olearczyk JJ, Spence DM et al (2003) Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 285:H693&#x2013;H700 <pub-id pub-id-type="pmid">12689860</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rhoden</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Endothelium-dependent relaxation of human pulmonary arteries</article-title>
          <source>Am J Physiol</source>
          <year>1987</year>
          <volume>252</volume>
          <fpage>H434</fpage>
          <lpage>H438</lpage>
        </citation>
        <citation citation-type="display-unstructured">Greenberg B, Rhoden K, Barnes PJ (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol 252:H434&#x2013;H438 <pub-id pub-id-type="pmid">3812755</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Remillard</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Fantozzi</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2004</year>
          <volume>287</volume>
          <fpage>C1192</fpage>
          <lpage>C1201</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhang S, Remillard CV, Fantozzi I et al (2004) ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 287:C1192&#x2013;C1201 <pub-id pub-id-type="pmid">15229105</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pendergast</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Potent P2Y<sub>6</sub> receptor mediated contractions in human cerebral arteries</article-title>
          <source>BMC Pharmacol</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>4</fpage>
        </citation>
        <citation citation-type="display-unstructured">Malmsj&#xF6; M, Hou M, Pendergast W et al (2003) Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3:4 <pub-id pub-id-type="pmid">12737633</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The role of adenosine triphosphate in migraine</article-title>
          <source>Biomed Pharmacother</source>
          <year>1989</year>
          <volume>43</volume>
          <fpage>727</fpage>
          <lpage>736</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (1989) The role of adenosine triphosphate in migraine. Biomed Pharmacother 43:727&#x2013;736 <pub-id pub-id-type="pmid">2701287</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waeber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moskowitz</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic implications of central and peripheral neurologic mechanisms in migraine</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>61</volume>
          <fpage>S9</fpage>
          <lpage>S20</lpage>
        </citation>
        <citation citation-type="display-unstructured">Waeber C, Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61:S9&#x2013;S20 <pub-id pub-id-type="pmid">14581653</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabbretti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>D&#x2019;Arco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fabbro</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Delayed upregulation of ATP P2X<sub>3</sub> receptors of trigeminal sensory neurons by calcitonin gene-related peptide</article-title>
          <source>J Neurosci</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>6163</fpage>
          <lpage>6171</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fabbretti E, D&#x2019;Arco M, Fabbro A et al (2006) Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26:6163&#x2013;6171 <pub-id pub-id-type="pmid">16763024</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peroutka</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Migraine: a chronic sympathetic nervous system disorder</article-title>
          <source>Headache</source>
          <year>2004</year>
          <volume>44</volume>
          <fpage>53</fpage>
          <lpage>64</lpage>
        </citation>
        <citation citation-type="display-unstructured">Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53&#x2013;64 <pub-id pub-id-type="pmid">14979884</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hansson</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Inflammation, atherosclerosis, and coronary artery disease</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <fpage>1685</fpage>
          <lpage>1695</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685&#x2013;1695 <pub-id pub-id-type="pmid">15843671</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shinozuka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shahdat</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antihypertensive effect of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery</article-title>
          <source>J Vasc Res</source>
          <year>1998</year>
          <volume>35</volume>
          <fpage>55</fpage>
          <lpage>62</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hashimoto M, Shinozuka K, Shahdat HM et al (1998) Antihypertensive effect of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. J Vasc Res 35:55&#x2013;62 <pub-id pub-id-type="pmid">9482696</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shinozuka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanabe</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term supplementation with a high cholesterol diet decreases the release of ATP from the caudal artery in aged rats</article-title>
          <source>Life Sci</source>
          <year>1998</year>
          <volume>63</volume>
          <fpage>1879</fpage>
          <lpage>1885</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hashimoto M, Shinozuka K, Tanabe Y et al (1998) Long-term supplementation with a high cholesterol diet decreases the release of ATP from the caudal artery in aged rats. Life Sci 63:1879&#x2013;1885 <pub-id pub-id-type="pmid">9825766</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karoon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet</article-title>
          <source>Br J Pharmacol</source>
          <year>1998</year>
          <volume>123</volume>
          <fpage>1016</fpage>
          <lpage>1021</lpage>
        </citation>
        <citation citation-type="display-unstructured">Karoon P, Burnstock G (1998) Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet. Br J Pharmacol 123:1016&#x2013;1021 <pub-id pub-id-type="pmid">9535033</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Virgilio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chiozzi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleotide receptors: an emerging family of regulatory molecules in blood cells</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>587</fpage>
          <lpage>600</lpage>
        </citation>
        <citation citation-type="display-unstructured">Di Virgilio F, Chiozzi P, Ferrari D et al (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587&#x2013;600 <pub-id pub-id-type="pmid">11157473</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jacobsen</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Bengtsson</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells</article-title>
          <source>BMC Immunol</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>16</fpage>
        </citation>
        <citation citation-type="display-unstructured">Wang L, Jacobsen SE, Bengtsson A et al (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5:16 <pub-id pub-id-type="pmid">15291969</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baricordi</surname>
              <given-names>OR</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname> Melchiorri</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes</article-title>
          <source>Blood</source>
          <year>1996</year>
          <volume>87</volume>
          <fpage>682</fpage>
          <lpage>690</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baricordi OR, Ferrari D, Melchiorri L et al (1996) An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87:682&#x2013;690 <pub-id pub-id-type="pmid">8555491</pub-id></citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aswad</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Minagawa</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X<sub>7</sub> receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>174</volume>
          <fpage>1971</fpage>
          <lpage>1979</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kawamura H, Aswad F, Minagawa M et al (2005) P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J Immunol 174:1971&#x2013;1979 <pub-id pub-id-type="pmid">15699125</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrari</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chiozzi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Falzoni</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP triggers IL-1&#x3B2; release by activating the purinergic P2Z receptor of human macrophages</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>159</volume>
          <fpage>1451</fpage>
          <lpage>1458</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferrari D, Chiozzi P, Falzoni S et al (1997) Extracellular ATP triggers IL-1&#x3B2; release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451&#x2013;1458 <pub-id pub-id-type="pmid">9233643</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hide</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ido</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Production and release of neuroprotective tumor necrosis factor by P2X<sub>7</sub> receptor-activated microglia</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
        </citation>
        <citation citation-type="display-unstructured">Suzuki T, Hide I, Ido K et al (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24:1&#x2013;7 <pub-id pub-id-type="pmid">14715932</pub-id></citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bendall</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Wiley</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>946</fpage>
          <lpage>951</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gu B, Bendall LJ, Wiley JS (1998) Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92:946&#x2013;951 <pub-id pub-id-type="pmid">9680363</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labasi</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Petrushova</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Absence of the P2X<sub>7</sub> receptor alters leukocyte function and attenuates an inflammatory response</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>6436</fpage>
          <lpage>6445</lpage>
        </citation>
        <citation citation-type="display-unstructured">Labasi JM, Petrushova N, Donovan C et al (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168:6436&#x2013;6445 <pub-id pub-id-type="pmid">12055263</pub-id></citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Idzko</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dichmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>100</volume>
          <fpage>925</fpage>
          <lpage>932</lpage>
        </citation>
        <citation citation-type="display-unstructured">Idzko M, Dichmann S, Ferrari D et al (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100:925&#x2013;932 <pub-id pub-id-type="pmid">12130504</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid-Antomarchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schmid-Alliana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Romey</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca<sup>2+</sup>-dependent K<sup>+</sup> channel</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>159</volume>
          <fpage>6209</fpage>
          <lpage>6215</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schmid-Antomarchi H, Schmid-Alliana A, Romey G et al (1997) Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol 159:6209&#x2013;6215 <pub-id pub-id-type="pmid">9550424</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hechler</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced atherosclerotic lesions in P2Y<sub>1</sub>/ApoE double knockout mice</article-title>
          <source>Purinergic Signalling</source>
          <year>2006</year>
          <volume>2</volume>
          <fpage>299</fpage>
        </citation>
        <citation citation-type="display-unstructured">Hechler B et al (2006) Reduced atherosclerotic lesions in P2Y1/ApoE double knockout mice. Purinergic Signalling 2:299 </citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duhant</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Schanden&#xE9;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bruyns</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>169</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
        </citation>
        <citation citation-type="display-unstructured">Duhant X, Schanden&#xE9; L, Bruyns C et al (2002) Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. J Immunol 169:15&#x2013;21 <pub-id pub-id-type="pmid">12077223</pub-id></citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaufmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>nMusset</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Limberg</surname>
              <given-names>SH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>&#x201C;Host tissue damage&#x201D; signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>32459</fpage>
          <lpage>32467</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaufmann A, Musset B, Limberg SH et al (2005) &#x201C;Host tissue damage&#x201D; signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 280:32459&#x2013;32467 <pub-id pub-id-type="pmid">16030017</pub-id></citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marteau</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>106</volume>
          <fpage>3860</fpage>
          <lpage>3866</lpage>
        </citation>
        <citation citation-type="display-unstructured">Marteau F, Gonzalez NS, Communi D et al (2005) Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106:3860&#x2013;3866 <pub-id pub-id-type="pmid">16118322</pub-id></citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amisten</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Melander</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wihlborg</surname>
              <given-names>AK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y<sub>11</sub></article-title>
          <source>Eur Heart J</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>13</fpage>
          <lpage>18</lpage>
        </citation>
        <citation citation-type="display-unstructured">Amisten S, Melander O, Wihlborg AK et al (2006) Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. Eur Heart J 28:13&#x2013;18 <pub-id pub-id-type="pmid">17135283</pub-id></citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawicki</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>McGowan-Jordan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bullard</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells</article-title>
          <source>Am J Physiol</source>
          <year>1995</year>
          <volume>268</volume>
          <fpage>L666</fpage>
          <lpage>L673</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dawicki DD, McGowan-Jordan J, Bullard S et al (1995) Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells. Am J Physiol 268:L666&#x2013;L673 <pub-id pub-id-type="pmid">7733307</pub-id></citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seiffert</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP&#x3B3;S enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling</article-title>
          <source>J Invest Dermatol</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>1017</fpage>
          <lpage>1027</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seiffert K, Ding W, Wagner JA et al (2006) ATP&#x3B3;S enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 126:1017&#x2013;1027 <pub-id pub-id-type="pmid">16410784</pub-id></citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seye</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The P2Y<sub>2</sub> nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>24960</fpage>
          <lpage>24965</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seye CI, Yu N, Jain R et al (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960&#x2013;24965 <pub-id pub-id-type="pmid">12714597</pub-id></citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seye</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez</surname>
              <given-names>FA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The P2Y<sub>2</sub> nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1)</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>35679</fpage>
          <lpage>35686</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seye CI, Yu N, Gonz&#xE1;lez FA et al (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279:35679&#x2013;35686 <pub-id pub-id-type="pmid">15175347</pub-id></citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seye</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Erb</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional P2Y<sub>2</sub> nucleotide receptors mediate uridine 5&#x2019;-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries</article-title>
          <source>Circulation</source>
          <year>2002</year>
          <volume>106</volume>
          <fpage>2720</fpage>
          <lpage>2726</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seye CI, Kong Q, Erb L et al (2002) Functional P2Y2 nucleotide receptors mediate uridine 5&#x2019;-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720&#x2013;2726 <pub-id pub-id-type="pmid">12438299</pub-id></citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Heistad</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Brody</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels</article-title>
          <source>Hypertension</source>
          <year>1980</year>
          <volume>2</volume>
          <fpage>419</fpage>
          <lpage>423</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hart MN, Heistad DD, Brody MJ (1980) Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 2:419&#x2013;423 <pub-id pub-id-type="pmid">7399625</pub-id></citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>H1089</fpage>
          <lpage>H1097</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D, Yoo H, Edvinsson L et al (1993) Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol 265:H1089&#x2013;H1097 <pub-id pub-id-type="pmid">7694483</pub-id></citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Heppel</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells</article-title>
          <source>J Cell Physiol</source>
          <year>1992</year>
          <volume>153</volume>
          <fpage>221</fpage>
          <lpage>233</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang DJ, Huang NN, Heppel LA (1992) Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153:221&#x2013;233 <pub-id pub-id-type="pmid">1358898</pub-id></citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malam-Souley</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seye</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gadeau</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells</article-title>
          <source>J Cell Physiol</source>
          <year>1996</year>
          <volume>166</volume>
          <fpage>57</fpage>
          <lpage>65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Malam-Souley R, Seye C, Gadeau AP et al (1996) Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol 166:57&#x2013;65 <pub-id pub-id-type="pmid">8557776</pub-id></citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wahlestedt</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells</article-title>
          <source>Eur J Pharmacol</source>
          <year>1995</year>
          <volume>289</volume>
          <fpage>135</fpage>
          <lpage>149</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D, You J, Wahlestedt C et al (1995) Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol 289:135&#x2013;149 <pub-id pub-id-type="pmid">7781705</pub-id></citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y<sub>6</sub> receptors</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2002</year>
          <volume>282</volume>
          <fpage>H784</fpage>
          <lpage>H792</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hou M, Harden TK, Kuhn CM et al (2002) UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors. Am J Physiol Heart Circ Physiol 282:H784&#x2013;H792 <pub-id pub-id-type="pmid">11788430</pub-id></citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilden</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Agazie</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>275</volume>
          <fpage>H1209</fpage>
          <lpage>H1215</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wilden PA, Agazie YM, Kaufman R et al (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275:H1209&#x2013;H1215 <pub-id pub-id-type="pmid">9746468</pub-id></citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauzeau</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Jeune</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cario-Toumaniantz</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y<sub>1</sub>, P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> receptors are coupled to Rho and Rho kinase activation in vascular myocytes</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2000</year>
          <volume>278</volume>
          <fpage>H1751</fpage>
          <lpage>H1761</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sauzeau V, Le Jeune H, Cario-Toumaniantz C et al (2000) P2Y1, P2Y2, P2Y4, and P2Y6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278:H1751&#x2013;H1761 <pub-id pub-id-type="pmid">10843869</pub-id></citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1996</year>
          <volume>222</volume>
          <fpage>652</fpage>
          <lpage>658</lpage>
        </citation>
        <citation citation-type="display-unstructured">Miyagi Y, Kobayashi S, Ahmed A et al (1996) P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. Biochem Biophys Res Commun 222:652&#x2013;658 <pub-id pub-id-type="pmid">8670259</pub-id></citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brunkwall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP</article-title>
          <source>Regul Pept</source>
          <year>1994</year>
          <volume>50</volume>
          <fpage>259</fpage>
          <lpage>265</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D, Brunkwall J, Edvinsson L (1994) Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept 50:259&#x2013;265 <pub-id pub-id-type="pmid">8016410</pub-id></citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erb</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ockerhausen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An RGD sequence in the P2Y<sub>2</sub> receptor interacts with &#x3B1;<sub>V</sub>&#x3B2;<sub>3</sub> integrins and is required for G<sub>o</sub>-mediated signal transduction</article-title>
          <source>J Cell Biol</source>
          <year>2001</year>
          <volume>153</volume>
          <fpage>491</fpage>
          <lpage>501</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erb L, Liu J, Ockerhausen J et al (2001) An RGD sequence in the P2Y2 receptor interacts with &#x3B1;V&#x3B2;3 integrins and is required for Go-mediated signal transduction. J Cell Biol 153:491&#x2013;501 <pub-id pub-id-type="pmid">11331301</pub-id></citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Douillet</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Milano</surname>
              <given-names>PM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2006</year>
          <volume>290</volume>
          <fpage>H1988</fpage>
          <lpage>H1996</lpage>
        </citation>
        <citation citation-type="display-unstructured">Robinson WP 3rd, Douillet CD, Milano PM et al (2006) ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway. Am J Physiol Heart Circ Physiol 290:H1988&#x2013;H1996 <pub-id pub-id-type="pmid">16361361</pub-id></citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaulet</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Desgranges</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Renault</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin</article-title>
          <source>Circ Res</source>
          <year>2001</year>
          <volume>89</volume>
          <fpage>772</fpage>
          <lpage>778</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chaulet H, Desgranges C, Renault MA et al (2001) Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89:772&#x2013;778 <pub-id pub-id-type="pmid">11679406</pub-id></citation>
      </ref>
      <ref id="CR135">
        <label>135.</label>
        <citation citation-type="other">Koziak K et al (2006) Adenovirus-mediated over-expression of CD39 inhibits neointima formation in rat aorta. Purinergic Signalling 2:Addendum</citation>
      </ref>
      <ref id="CR136">
        <label>136.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takigami</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Guckelberger</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection</article-title>
          <source>Mol Med</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>743</fpage>
          <lpage>752</lpage>
        </citation>
        <citation citation-type="display-unstructured">Imai M, Takigami K, Guckelberger O et al (1999) Modulation of nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med 5:743&#x2013;752 <pub-id pub-id-type="pmid">10656876</pub-id></citation>
      </ref>
      <ref id="CR137">
        <label>137.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillois</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chaulet</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Belloc</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration</article-title>
          <source>Circ Res</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>678</fpage>
          <lpage>681</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pillois X, Chaulet H, Belloc I et al (2002) Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res 90:678&#x2013;681 <pub-id pub-id-type="pmid">11934835</pub-id></citation>
      </ref>
      <ref id="CR138">
        <label>138.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ralevic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Belai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed</article-title>
          <source>Eur J Pharmacol</source>
          <year>1995</year>
          <volume>286</volume>
          <fpage>193</fpage>
          <lpage>199</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ralevic V, Belai A, Burnstock G (1995) Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur J Pharmacol 286:193&#x2013;199 <pub-id pub-id-type="pmid">8605956</pub-id></citation>
      </ref>
      <ref id="CR139">
        <label>139.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xFC;r</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ozturk</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Altered relaxant responses to adenosine and adenosine 5&#x2019;-triphosphate in the corpus cavernosum from men and rats with diabetes</article-title>
          <source>Pharmacology</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>105</fpage>
          <lpage>112</lpage>
        </citation>
        <citation citation-type="display-unstructured">G&#xFC;r S, Ozturk B (2000) Altered relaxant responses to adenosine and adenosine 5&#x2019;-triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 60:105&#x2013;112 <pub-id pub-id-type="pmid">10657760</pub-id></citation>
      </ref>
      <ref id="CR140">
        <label>140.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sprague</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Stephenson</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Bowles</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced expression of G<sub>i</sub> in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release</article-title>
          <source>Diabetes</source>
          <year>2006</year>
          <volume>55</volume>
          <fpage>3588</fpage>
          <lpage>3593</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sprague RS, Stephenson AH, Bowles EA et al (2006) Reduced expression of Gi in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 55:3588&#x2013;3593 <pub-id pub-id-type="pmid">17130508</pub-id></citation>
      </ref>
      <ref id="CR141">
        <label>141.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parodi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Aguayo</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y<sub>2</sub> purinoceptors in human umbilical vein endothelial cells</article-title>
          <source>Circ Res</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>570</fpage>
          <lpage>577</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parodi J, Flores C, Aguayo C et al (2002) Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells. Circ Res 90:570&#x2013;577 <pub-id pub-id-type="pmid">11909821</pub-id></citation>
      </ref>
      <ref id="CR142">
        <label>142.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hellman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dansk</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grapengiesser</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Pancreatic &#x3B2;-cells communicate via intermittent release of ATP</article-title>
          <source>Am J Physiol Endocrinol Metab</source>
          <year>2004</year>
          <volume>286</volume>
          <fpage>E759</fpage>
          <lpage>E765</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hellman B, Dansk H, Grapengiesser E (2004) Pancreatic &#x3B2;-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 286:E759&#x2013;E765 <pub-id pub-id-type="pmid">14722025</pub-id></citation>
      </ref>
      <ref id="CR143">
        <label>143.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nilsson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High glucose activates nuclear factor of activated T cells in native vascular smooth muscle</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>794</fpage>
          <lpage>800</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nilsson J, Nilsson LM, Chen YW et al (2006) High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26:794&#x2013;800 <pub-id pub-id-type="pmid">16469950</pub-id></citation>
      </ref>
      <ref id="CR144">
        <label>144.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pacaud</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Malam-Souley</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Loirand</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP raises [Ca<sup>2+</sup>]<sub>i</sub> via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes</article-title>
          <source>Am J Physiol</source>
          <year>1995</year>
          <volume>269</volume>
          <fpage>H30</fpage>
          <lpage>H36</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pacaud P, Malam-Souley R, Loirand G et al (1995) ATP raises [Ca2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am J Physiol 269:H30&#x2013;H36 <pub-id pub-id-type="pmid">7631861</pub-id></citation>
      </ref>
      <ref id="CR145">
        <label>145.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>TE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1998</year>
          <volume>248</volume>
          <fpage>864</fpage>
          <lpage>870</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D, Hou M, Webb TE et al (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248:864&#x2013;870 <pub-id pub-id-type="pmid">9704019</pub-id></citation>
      </ref>
      <ref id="CR146">
        <label>146.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>M&#xF6;ller</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MAPKK-dependent growth factor-induced upregulation of P2Y<sub>2</sub> receptors in vascular smooth muscle cells</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1999</year>
          <volume>258</volume>
          <fpage>648</fpage>
          <lpage>652</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hou M, M&#xF6;ller S, Edvinsson L et al (1999) MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 258:648&#x2013;652 <pub-id pub-id-type="pmid">10329439</pub-id></citation>
      </ref>
      <ref id="CR147">
        <label>147.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>M&#xF6;ller</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytokines induce upregulation of vascular P2Y<sub>2</sub> receptors and increased mitogenic responses to UTP and ATP</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>2064</fpage>
          <lpage>2069</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hou M, M&#xF6;ller S, Edvinsson L et al (2000) Cytokines induce upregulation of vascular P2Y2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 20:2064&#x2013;2069 <pub-id pub-id-type="pmid">10978250</pub-id></citation>
      </ref>
      <ref id="CR148">
        <label>148.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seye</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Gadeau</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Daret</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Overexpression of P2Y<sub>2</sub> purinoceptor in intimal lesions of the rat aorta</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>3602</fpage>
          <lpage>3610</lpage>
        </citation>
        <citation citation-type="display-unstructured">Seye CI, Gadeau AP, Daret D et al (1997) Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17:3602&#x2013;3610 <pub-id pub-id-type="pmid">9437211</pub-id></citation>
      </ref>
      <ref id="CR149">
        <label>149.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seye</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cloning, up-regulation, and mitogenic role of porcine P2Y<sub>2</sub> receptor in coronary artery smooth muscle cells</article-title>
          <source>Mol Pharmacol</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>1265</fpage>
          <lpage>1274</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shen J, Seye CI, Wang M et al (2004) Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66:1265&#x2013;1274 <pub-id pub-id-type="pmid">15280443</pub-id></citation>
      </ref>
      <ref id="CR150">
        <label>150.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hogarth</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Sandbo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Taurin</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2004</year>
          <volume>287</volume>
          <fpage>C449</fpage>
          <lpage>C456</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hogarth DK, Sandbo N, Taurin S et al (2004) Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am J Physiol Cell Physiol 287:C449&#x2013;C456 <pub-id pub-id-type="pmid">15238360</pub-id></citation>
      </ref>
      <ref id="CR151">
        <label>151.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>1370</fpage>
          <lpage>1376</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang L, Andersson M, Karlsson L et al (2003) Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol 23:1370&#x2013;1376 <pub-id pub-id-type="pmid">12791671</pub-id></citation>
      </ref>
      <ref id="CR152">
        <label>152.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daele</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Coevorden</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Roger</surname>
              <given-names>PP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of adenine nucleotides on the proliferation of aortic endothelial cells</article-title>
          <source>Circ Res</source>
          <year>1992</year>
          <volume>70</volume>
          <fpage>82</fpage>
          <lpage>90</lpage>
        </citation>
        <citation citation-type="display-unstructured">Van Daele P, Van Coevorden A, Roger PP et al (1992) Effects of adenine nucleotides on the proliferation of aortic endothelial cells. Circ Res 70:82&#x2013;90 <pub-id pub-id-type="pmid">1727689</pub-id></citation>
      </ref>
      <ref id="CR153">
        <label>153.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaczmarek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Erb</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Koziak</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways</article-title>
          <source>Thromb Haemost</source>
          <year>2005</year>
          <volume>93</volume>
          <fpage>735</fpage>
          <lpage>742</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaczmarek E, Erb L, Koziak K et al (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93:735&#x2013;742 <pub-id pub-id-type="pmid">15841322</pub-id></citation>
      </ref>
      <ref id="CR154">
        <label>154.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerasimovskaya</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Davie</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular adenosine triphosphate: a potential regulator of vasa vasorum neovascularization in hypoxia-induced pulmonary vascular remodeling</article-title>
          <source>Chest</source>
          <year>2005</year>
          <volume>128</volume>
          <issue>6 Suppl</issue>
          <fpage>608S</fpage>
          <lpage>610S</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gerasimovskaya EV, Davie NJ, Ahmad S et al (2005) Extracellular adenosine triphosphate: a potential regulator of vasa vasorum neovascularization in hypoxia-induced pulmonary vascular remodeling. Chest 128(6 Suppl):608S&#x2013;610S <pub-id pub-id-type="pmid">16373860</pub-id></citation>
      </ref>
      <ref id="CR155">
        <label>155.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eltzschig</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Ibla</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Furuta</surname>
              <given-names>GT</given-names>
            </name>
          </person-group>
          <article-title>Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors</article-title>
          <source>J Exp Med</source>
          <year>2003</year>
          <volume>198</volume>
          <fpage>783</fpage>
          <lpage>796</lpage>
        </citation>
        <citation citation-type="display-unstructured">Eltzschig HK, Ibla JC, Furuta GT (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783&#x2013;796 <pub-id pub-id-type="pmid">12939345</pub-id></citation>
      </ref>
      <ref id="CR156">
        <label>156.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goepfert</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sundberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>S&#xE9;vigny</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disordered cellular migration and angiogenesis in cd39-null mice</article-title>
          <source>Circulation</source>
          <year>2001</year>
          <volume>104</volume>
          <fpage>3109</fpage>
          <lpage>3115</lpage>
        </citation>
        <citation citation-type="display-unstructured">Goepfert C, Sundberg C, S&#xE9;vigny J et al (2001) Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104:3109&#x2013;3115 <pub-id pub-id-type="pmid">11748109</pub-id></citation>
      </ref>
      <ref id="CR157">
        <label>157.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cario-Toumaniantz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Loirand</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ladoux</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X<sub>7</sub> receptor activation-induced contraction and lysis in human saphenous vein smooth muscle</article-title>
          <source>Circ Res</source>
          <year>1998</year>
          <volume>83</volume>
          <fpage>196</fpage>
          <lpage>203</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cario-Toumaniantz C, Loirand G, Ladoux A et al (1998) P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83:196&#x2013;203 <pub-id pub-id-type="pmid">9686759</pub-id></citation>
      </ref>
      <ref id="CR158">
        <label>158.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metcalfe</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Purinoceptor expression on keratinocytes reflects their function in the epidermis during chronic venous insufficiency</article-title>
          <source>Arch Dermatol Res</source>
          <year>2006</year>
          <volume>298</volume>
          <fpage>301</fpage>
          <lpage>307</lpage>
        </citation>
        <citation citation-type="display-unstructured">Metcalfe MJ, Baker DM, Burnstock G (2006) Purinoceptor expression on keratinocytes reflects their function in the epidermis during chronic venous insufficiency. Arch Dermatol Res 298:301&#x2013;307 <pub-id pub-id-type="pmid">16967306</pub-id></citation>
      </ref>
      <ref id="CR159">
        <label>159.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clemens</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia</article-title>
          <source>J Physiol</source>
          <year>1981</year>
          <volume>312</volume>
          <fpage>143</fpage>
          <lpage>158</lpage>
        </citation>
        <citation citation-type="display-unstructured">Clemens MG, Forrester T (1981) Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. J Physiol 312:143&#x2013;158 <pub-id pub-id-type="pmid">7264990</pub-id></citation>
      </ref>
      <ref id="CR160">
        <label>160.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanov</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rubino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart</article-title>
          <source>Life Sci</source>
          <year>1998</year>
          <volume>62</volume>
          <fpage>697</fpage>
          <lpage>703</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bogdanov Y, Rubino A, Burnstock G (1998) Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. Life Sci 62:697&#x2013;703 <pub-id pub-id-type="pmid">9489506</pub-id></citation>
      </ref>
      <ref id="CR161">
        <label>161.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wihlborg</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Balogh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y<sub>2</sub> and P2Y<sub>6</sub> receptors on cardiomyocytes and release of UTP in man during myocardial infarction</article-title>
          <source>Circ Res</source>
          <year>2006</year>
          <volume>98</volume>
          <fpage>970</fpage>
          <lpage>976</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wihlborg AK, Balogh J, Wang L et al (2006) Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98:970&#x2013;976 <pub-id pub-id-type="pmid">16543499</pub-id></citation>
      </ref>
      <ref id="CR162">
        <label>162.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danziger</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Raffaeli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moreno-Sanchez</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes</article-title>
          <source>Cell Calcium</source>
          <year>1988</year>
          <volume>9</volume>
          <fpage>193</fpage>
          <lpage>199</lpage>
        </citation>
        <citation citation-type="display-unstructured">Danziger RS, Raffaeli S, Moreno-Sanchez R et al (1988) Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes. Cell Calcium 9:193&#x2013;199 <pub-id pub-id-type="pmid">3191528</pub-id></citation>
      </ref>
      <ref id="CR163">
        <label>163.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes</article-title>
          <source>Circ Res</source>
          <year>1996</year>
          <volume>78</volume>
          <fpage>525</fpage>
          <lpage>535</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zheng JS, Boluyt MO, Long X et al (1996) Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res 78:525&#x2013;535 <pub-id pub-id-type="pmid">8635209</pub-id></citation>
      </ref>
      <ref id="CR164">
        <label>164.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podrasky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>BT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor</article-title>
          <source>Am J Physiol</source>
          <year>1997</year>
          <volume>273</volume>
          <fpage>H2380</fpage>
          <lpage>H2387</lpage>
        </citation>
        <citation citation-type="display-unstructured">Podrasky E, Xu D, Liang BT (1997) A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor. Am J Physiol 273:H2380&#x2013;H2387 <pub-id pub-id-type="pmid">9374775</pub-id></citation>
      </ref>
      <ref id="CR165">
        <label>165.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mei</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2001</year>
          <volume>281</volume>
          <fpage>H334</fpage>
          <lpage>H341</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mei Q, Liang BT (2001) P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 281:H334&#x2013;H341 <pub-id pub-id-type="pmid">11406501</pub-id></citation>
      </ref>
      <ref id="CR166">
        <label>166.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Froldi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pandolfo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chinellato</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual effect of ATP and UTP on rat atria: which types of receptors are involved?</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1994</year>
          <volume>349</volume>
          <fpage>381</fpage>
          <lpage>386</lpage>
        </citation>
        <citation citation-type="display-unstructured">Froldi G, Pandolfo L, Chinellato A et al (1994) Dual effect of ATP and UTP on rat atria: which types of receptors are involved? Naunyn Schmiedebergs Arch Pharmacol 349:381&#x2013;386 <pub-id pub-id-type="pmid">8058110</pub-id></citation>
      </ref>
      <ref id="CR167">
        <label>167.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scamps</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vassort</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological profile of the ATP-mediated increase in L-type calcium current amplitude and activation of a non-specific cationic current in rat ventricular cells</article-title>
          <source>Br J Pharmacol</source>
          <year>1994</year>
          <volume>113</volume>
          <fpage>982</fpage>
          <lpage>986</lpage>
        </citation>
        <citation citation-type="display-unstructured">Scamps F, Vassort G (1994) Pharmacological profile of the ATP-mediated increase in L-type calcium current amplitude and activation of a non-specific cationic current in rat ventricular cells. Br J Pharmacol 113:982&#x2013;986 <pub-id pub-id-type="pmid">7858894</pub-id></citation>
      </ref>
      <ref id="CR168">
        <label>168.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vahlensieck</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bokn&#xED;k</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gombosov&#xE1;</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>1999</year>
          <volume>288</volume>
          <fpage>805</fpage>
          <lpage>813</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vahlensieck U, Bokn&#xED;k P, Gombosov&#xE1; I et al (1999) Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 288:805&#x2013;813 <pub-id pub-id-type="pmid">9918592</pub-id></citation>
      </ref>
      <ref id="CR169">
        <label>169.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balogh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wihlborg</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Isackson</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y<sub>11</sub>-like receptors</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2005</year>
          <volume>39</volume>
          <fpage>223</fpage>
          <lpage>230</lpage>
        </citation>
        <citation citation-type="display-unstructured">Balogh J, Wihlborg AK, Isackson H et al (2005) Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J Mol Cell Cardiol 39:223&#x2013;230 <pub-id pub-id-type="pmid">15893764</pub-id></citation>
      </ref>
      <ref id="CR170">
        <label>170.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flitney</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Inotropic responses of the frog ventricle to adenosine triphosphate and related changes in endogenous cyclic nucleotides</article-title>
          <source>J Physiol</source>
          <year>1980</year>
          <volume>304</volume>
          <fpage>21</fpage>
          <lpage>42</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flitney FW, Singh J (1980) Inotropic responses of the frog ventricle to adenosine triphosphate and related changes in endogenous cyclic nucleotides. J Physiol 304:21&#x2013;42 <pub-id pub-id-type="pmid">6255141</pub-id></citation>
      </ref>
      <ref id="CR171">
        <label>171.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puceat</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bony</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jaconi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Specific activation of adenylyl cyclase V by a purinergic agonist</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>431</volume>
          <fpage>189</fpage>
          <lpage>194</lpage>
        </citation>
        <citation citation-type="display-unstructured">Puceat M, Bony C, Jaconi M et al (1998) Specific activation of adenylyl cyclase V by a purinergic agonist. FEBS Lett 431:189&#x2013;194 <pub-id pub-id-type="pmid">9708900</pub-id></citation>
      </ref>
      <ref id="CR172">
        <label>172.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Govaerts</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Parmentier</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase</article-title>
          <source>J Biol Chem</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>31969</fpage>
          <lpage>31973</lpage>
        </citation>
        <citation citation-type="display-unstructured">Communi D, Govaerts C, Parmentier M et al (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969&#x2013;31973 <pub-id pub-id-type="pmid">9405388</pub-id></citation>
      </ref>
      <ref id="CR173">
        <label>173.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Robaye</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boeynaems</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological characterization of the human P2Y<sub>11</sub> receptor</article-title>
          <source>Br J Pharmacol</source>
          <year>1999</year>
          <volume>128</volume>
          <fpage>1199</fpage>
          <lpage>1206</lpage>
        </citation>
        <citation citation-type="display-unstructured">Communi D, Robaye B, Boeynaems JM (1999) Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128:1199&#x2013;1206 <pub-id pub-id-type="pmid">10578132</pub-id></citation>
      </ref>
      <ref id="CR174">
        <label>174.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zambon</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Meszaros</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y<sub>2</sub> receptor of MDCK cells: cloning, expression, and cell-specific signaling</article-title>
          <source>Am J Physiol Renal Physiol</source>
          <year>2000</year>
          <volume>279</volume>
          <fpage>F1045</fpage>
          <lpage>F1052</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zambon AC, Hughes RJ, Meszaros JG et al (2000) P2Y2 receptor of MDCK cells: cloning, expression, and cell-specific signaling. Am J Physiol Renal Physiol 279:F1045&#x2013;F1052 <pub-id pub-id-type="pmid">11097622</pub-id></citation>
      </ref>
      <ref id="CR175">
        <label>175.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>M&#xF6;ller</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increase in cardiac P2X<sub>1</sub>-and P2Y<sub>2</sub>-receptor mRNA levels in congestive heart failure</article-title>
          <source>Life Sci</source>
          <year>1999</year>
          <volume>65</volume>
          <fpage>1195</fpage>
          <lpage>1206</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hou M, Malmsj&#xF6; M, M&#xF6;ller S et al (1999) Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci 65:1195&#x2013;1206 <pub-id pub-id-type="pmid">10503935</pub-id></citation>
      </ref>
      <ref id="CR176">
        <label>176.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Froldi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Varani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chinellato</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X-purinoceptors in the heart: actions of ATP and UTP</article-title>
          <source>Life Sci</source>
          <year>1997</year>
          <volume>60</volume>
          <fpage>1419</fpage>
          <lpage>1430</lpage>
        </citation>
        <citation citation-type="display-unstructured">Froldi G, Varani K, Chinellato A et al (1997) P2X-purinoceptors in the heart: actions of ATP and UTP. Life Sci 60:1419&#x2013;1430 <pub-id pub-id-type="pmid">9126862</pub-id></citation>
      </ref>
      <ref id="CR177">
        <label>177.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Froldi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ragazzi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Caparrotta</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Do ATP and UTP involve cGMP in positive inotropism on rat atria?</article-title>
          <source>Comp Biochem Physiol C Toxicol Pharmacol</source>
          <year>2001</year>
          <volume>128</volume>
          <fpage>265</fpage>
          <lpage>274</lpage>
        </citation>
        <citation citation-type="display-unstructured">Froldi G, Ragazzi E, Caparrotta L (2001) Do ATP and UTP involve cGMP in positive inotropism on rat atria? Comp Biochem Physiol C Toxicol Pharmacol 128:265&#x2013;274 <pub-id pub-id-type="pmid">11239839</pub-id></citation>
      </ref>
      <ref id="CR178">
        <label>178.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erlinge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Harnek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heusden</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uridine triphosphate (UTP) is released during cardiac ischemia</article-title>
          <source>Int J Cardiol</source>
          <year>2005</year>
          <volume>100</volume>
          <fpage>427</fpage>
          <lpage>433</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erlinge D, Harnek J, van Heusden C et al (2005) Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol 100:427&#x2013;433 <pub-id pub-id-type="pmid">15837087</pub-id></citation>
      </ref>
      <ref id="CR179">
        <label>179.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borna</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lazarowski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Heusden</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resistance to aspirin is increased by ST&#x2013;elevation myocardial infarction and correlates with adenosine diphosphate levels</article-title>
          <source>Thromb J</source>
          <year>2005</year>
          <volume>3</volume>
          <fpage>10</fpage>
        </citation>
        <citation citation-type="display-unstructured">Borna C, Lazarowski E, van Heusden C et al (2005) Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3:10 <pub-id pub-id-type="pmid">16045804</pub-id></citation>
      </ref>
      <ref id="CR180">
        <label>180.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kittel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kiss</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>M&#xFC;llner</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of NTPDase1 and caveolins in human cardiovascular disease</article-title>
          <source>Histochem Cell Biol</source>
          <year>2005</year>
          <volume>124</volume>
          <fpage>51</fpage>
          <lpage>59</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kittel A, Kiss AL, M&#xFC;llner N et al (2005) Expression of NTPDase1 and caveolins in human cardiovascular disease. Histochem Cell Biol 124:51&#x2013;59 <pub-id pub-id-type="pmid">16028070</pub-id></citation>
      </ref>
      <ref id="CR181">
        <label>181.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunduz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kasseckert</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>H&#xE4;rtel</surname>
              <given-names>FV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells</article-title>
          <source>Cardiovasc Res</source>
          <year>2006</year>
          <volume>71</volume>
          <fpage>764</fpage>
          <lpage>773</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gunduz D, Kasseckert SA, H&#xE4;rtel FV et al (2006) Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Cardiovasc Res 71:764&#x2013;773 <pub-id pub-id-type="pmid">16836989</pub-id></citation>
      </ref>
      <ref id="CR182">
        <label>182.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pham</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>287</fpage>
          <lpage>292</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pham TM, Morris JB, Arthur JF et al (2003) UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. J Mol Cell Cardiol 35:287&#x2013;292 <pub-id pub-id-type="pmid">12676543</pub-id></citation>
      </ref>
      <ref id="CR183">
        <label>183.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>O&#x2019;Neill</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes</article-title>
          <source>Circ Res</source>
          <year>1994</year>
          <volume>74</volume>
          <fpage>1034</fpage>
          <lpage>1041</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zheng JS, Boluyt MO, O&#x2019;Neill L et al (1994) Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res 74:1034&#x2013;1041 <pub-id pub-id-type="pmid">8187273</pub-id></citation>
      </ref>
      <ref id="CR184">
        <label>184.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Kenney</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>UTP transactivates epidermal growth factor receptors and promotes cardiomyocyte hypertrophy despite inhibiting transcription of the hypertrophic marker gene, atrial natriuretic peptide</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>8740</fpage>
          <lpage>8746</lpage>
        </citation>
        <citation citation-type="display-unstructured">Morris JB, Pham TM, Kenney B et al (2004) UTP transactivates epidermal growth factor receptors and promotes cardiomyocyte hypertrophy despite inhibiting transcription of the hypertrophic marker gene, atrial natriuretic peptide. J Biol Chem 279:8740&#x2013;8746 <pub-id pub-id-type="pmid">14676212</pub-id></citation>
      </ref>
      <ref id="CR185">
        <label>185.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yitzhaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shneyvays</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress</article-title>
          <source>Biochem Pharmacol</source>
          <year>2005</year>
          <volume>69</volume>
          <fpage>1215</fpage>
          <lpage>1223</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yitzhaki S, Shneyvays V, Jacobson KA et al (2005) Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochem Pharmacol 69:1215&#x2013;1223 <pub-id pub-id-type="pmid">15794942</pub-id></citation>
      </ref>
      <ref id="CR186">
        <label>186.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yitzhaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shainberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cheporko</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uridine-5&#x2019;-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct</article-title>
          <source>Biochem Pharmacol</source>
          <year>2006</year>
          <volume>72</volume>
          <fpage>949</fpage>
          <lpage>955</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yitzhaki S, Shainberg A, Cheporko Y et al (2006) Uridine-5&#x2019;-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochem Pharmacol 72:949&#x2013;955 <pub-id pub-id-type="pmid">16939682</pub-id></citation>
      </ref>
      <ref id="CR187">
        <label>187.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saini</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Musat</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction</article-title>
          <source>Br J Pharmacol</source>
          <year>2005</year>
          <volume>144</volume>
          <fpage>202</fpage>
          <lpage>211</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saini HK, Shao Q, Musat S et al (2005) Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction. Br J Pharmacol 144:202&#x2013;211 <pub-id pub-id-type="pmid">15665860</pub-id></citation>
      </ref>
      <ref id="CR188">
        <label>188.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banfi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ferrario</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vincenti</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2 receptors in human heart: upregulation of P2X<sub>6</sub> in patients undergoing heart transplantation, interaction with TNF&#x3B1; and potential role in myocardial cell death</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2005</year>
          <volume>39</volume>
          <fpage>929</fpage>
          <lpage>939</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banfi C, Ferrario S, De Vincenti O et al (2005) P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNF&#x3B1; and potential role in myocardial cell death. J Mol Cell Cardiol 39:929&#x2013;939 <pub-id pub-id-type="pmid">16242142</pub-id></citation>
      </ref>
      <ref id="CR189">
        <label>189.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmsj&#xF6;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bergdahl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>M&#xF6;ller</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congestive heart failure induces downregulation of P2X<sub>1</sub>-receptors in resistance arteries</article-title>
          <source>Cardiovasc Res</source>
          <year>1999</year>
          <volume>43</volume>
          <fpage>219</fpage>
          <lpage>227</lpage>
        </citation>
        <citation citation-type="display-unstructured">Malmsj&#xF6; M, Bergdahl A, M&#xF6;ller S et al (1999) Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. Cardiovasc Res 43:219&#x2013;227 <pub-id pub-id-type="pmid">10536707</pub-id></citation>
      </ref>
      <ref id="CR190">
        <label>190.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sonin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A beneficial role of cardiac P2X<sub>4</sub> receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2004</year>
          <volume>287</volume>
          <fpage>H1096</fpage>
          <lpage>H1103</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yang A, Sonin D, Jones L et al (2004) A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am J Physiol Heart Circ Physiol 287:H1096&#x2013;H1103 <pub-id pub-id-type="pmid">15130891</pub-id></citation>
      </ref>
      <ref id="CR191">
        <label>191.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horackova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Armour</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Purinergic modulation of adult guinea pig cardiomyocytes in long term cultures and co-cultures with extracardiac or intrinsic cardiac neurones</article-title>
          <source>Cardiovasc Res</source>
          <year>1994</year>
          <volume>28</volume>
          <fpage>673</fpage>
          <lpage>679</lpage>
        </citation>
        <citation citation-type="display-unstructured">Horackova M, Huang MH, Armour JA (1994) Purinergic modulation of adult guinea pig cardiomyocytes in long term cultures and co-cultures with extracardiac or intrinsic cardiac neurones. Cardiovasc Res 28:673&#x2013;679 <pub-id pub-id-type="pmid">8025912</pub-id></citation>
      </ref>
      <ref id="CR192">
        <label>192.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bardini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Keogh</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2X<sub>1</sub> receptors are closely associated with connexin 43 in human ventricular myocardium</article-title>
          <source>Int J Cardiol</source>
          <year>2005</year>
          <volume>98</volume>
          <fpage>291</fpage>
          <lpage>297</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jiang L, Bardini M, Keogh A et al (2005) P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. Int J Cardiol 98:291&#x2013;297 <pub-id pub-id-type="pmid">15686781</pub-id></citation>
      </ref>
      <ref id="CR193">
        <label>193.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaarder</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jonsen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Laland</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets</article-title>
          <source>Nature</source>
          <year>1961</year>
          <volume>192</volume>
          <fpage>531</fpage>
          <lpage>532</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gaarder A, Jonsen J, Laland S et al (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192:531&#x2013;532 <pub-id pub-id-type="pmid">13896038</pub-id></citation>
      </ref>
      <ref id="CR194">
        <label>194.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daniel</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Dangelmaier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>2024</fpage>
          <lpage>2029</lpage>
        </citation>
        <citation citation-type="display-unstructured">Daniel JL, Dangelmaier C, Jin J et al (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024&#x2013;2029 <pub-id pub-id-type="pmid">9442039</pub-id></citation>
      </ref>
      <ref id="CR195">
        <label>195.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kunapuli</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>8070</fpage>
          <lpage>8074</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jin J, Kunapuli SP (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 95:8070&#x2013;8074 <pub-id pub-id-type="pmid">9653141</pub-id></citation>
      </ref>
      <ref id="CR196">
        <label>196.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Kunapuli</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis for ADP-induced platelet activation. II. The P2Y<sub>1</sub> receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>2030</fpage>
          <lpage>2034</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jin J, Daniel JL, Kunapuli SP (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273:2030&#x2013;2034 <pub-id pub-id-type="pmid">9442040</pub-id></citation>
      </ref>
      <ref id="CR197">
        <label>197.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunapuli</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Dorsam</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Platelet purinergic receptors</article-title>
          <source>Curr Opin Pharmacol</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>175</fpage>
          <lpage>180</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kunapuli SP, Dorsam RT, Kim S et al (2003) Platelet purinergic receptors. Curr Opin Pharmacol 3:175&#x2013;180 <pub-id pub-id-type="pmid">12681240</pub-id></citation>
      </ref>
      <ref id="CR198">
        <label>198.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gachet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hechler</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The platelet P2 receptors in thrombosis</article-title>
          <source>Semin Thromb Hemost</source>
          <year>2005</year>
          <volume>31</volume>
          <fpage>162</fpage>
          <lpage>167</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gachet C, Hechler B (2005) The platelet P2 receptors in thrombosis. Semin Thromb Hemost 31:162&#x2013;167 <pub-id pub-id-type="pmid">15852219</pub-id></citation>
      </ref>
      <ref id="CR199">
        <label>199.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Prosser</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Agans</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs</article-title>
          <source>J Clin Invest</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>1591</fpage>
          <lpage>1598</lpage>
        </citation>
        <citation citation-type="display-unstructured">Foster CJ, Prosser DM, Agans JM et al (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107:1591&#x2013;1598 <pub-id pub-id-type="pmid">11413167</pub-id></citation>
      </ref>
      <ref id="CR200">
        <label>200.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabre</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Latour</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y<sub>1</sub>-deficient mice</article-title>
          <source>Nat Med</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>1199</fpage>
          <lpage>1202</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fabre JE, Nguyen M, Latour A et al (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199&#x2013;1202 <pub-id pub-id-type="pmid">10502826</pub-id></citation>
      </ref>
      <ref id="CR201">
        <label>201.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alex</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klocke</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Platelet ADP receptors contribute to the initiation of intravascular coagulation</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>594</fpage>
          <lpage>600</lpage>
        </citation>
        <citation citation-type="display-unstructured">Leon C, Alex M, Klocke A et al (2004) Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103:594&#x2013;600 <pub-id pub-id-type="pmid">12969982</pub-id></citation>
      </ref>
      <ref id="CR202">
        <label>202.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gachet</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The platelet P2 receptors as molecular targets for old and new antiplatelet drugs</article-title>
          <source>Pharmacol Ther</source>
          <year>2005</year>
          <volume>108</volume>
          <fpage>180</fpage>
          <lpage>192</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gachet C (2005) The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther 108:180&#x2013;192 <pub-id pub-id-type="pmid">15955565</pub-id></citation>
      </ref>
      <ref id="CR203">
        <label>203.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hechler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Freund</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y<sub>1</sub> receptor-null mice</article-title>
          <source>J Clin Invest</source>
          <year>1999</year>
          <volume>104</volume>
          <fpage>1731</fpage>
          <lpage>1737</lpage>
        </citation>
        <citation citation-type="display-unstructured">Leon C, Hechler B, Freund M et al (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 104:1731&#x2013;1737 <pub-id pub-id-type="pmid">10606627</pub-id></citation>
      </ref>
      <ref id="CR204">
        <label>204.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahaut-Smith</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Tolhurst</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Emerging roles for P2X<sub>1</sub> receptors in platelet activation</article-title>
          <source>Platelets</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>131</fpage>
          <lpage>144</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mahaut-Smith MP, Tolhurst G, Evans RJ (2004) Emerging roles for P2X1 receptors in platelet activation. Platelets 15:131&#x2013;144 <pub-id pub-id-type="pmid">15203715</pub-id></citation>
      </ref>
      <ref id="CR205">
        <label>205.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birk</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Leno</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>HD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interaction between ATP and catecholamines in stimulation of platelet aggregation</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2003</year>
          <volume>284</volume>
          <fpage>H619</fpage>
          <lpage>H625</lpage>
        </citation>
        <citation citation-type="display-unstructured">Birk AV, Leno E, Robertson HD et al (2003) Interaction between ATP and catecholamines in stimulation of platelet aggregation. Am J Physiol Heart Circ Physiol 284:H619&#x2013;H625 <pub-id pub-id-type="pmid">12388296</pub-id></citation>
      </ref>
      <ref id="CR206">
        <label>206.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE9;vigny</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sundberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>2801</fpage>
          <lpage>2809</lpage>
        </citation>
        <citation citation-type="display-unstructured">S&#xE9;vigny J, Sundberg C, Braun N et al (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99:2801&#x2013;2809 <pub-id pub-id-type="pmid">11929769</pub-id></citation>
      </ref>
      <ref id="CR207">
        <label>207.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robson</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Kaczmarek</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of ATP diphosphohydrolase activity with endothelial cell activation</article-title>
          <source>J Exp Med</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>153</fpage>
          <lpage>163</lpage>
        </citation>
        <citation citation-type="display-unstructured">Robson SC, Kaczmarek E, Siegel JB et al (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153&#x2013;163 <pub-id pub-id-type="pmid">8996251</pub-id></citation>
      </ref>
      <ref id="CR208">
        <label>208.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koyamada</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyatake</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Candinas</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apyrase administration prolongs discordant xenograft survival</article-title>
          <source>Transplantation</source>
          <year>1996</year>
          <volume>62</volume>
          <fpage>1739</fpage>
          <lpage>1743</lpage>
        </citation>
        <citation citation-type="display-unstructured">Koyamada N, Miyatake T, Candinas D et al (1996) Apyrase administration prolongs discordant xenograft survival. Transplantation 62:1739&#x2013;1743 <pub-id pub-id-type="pmid">8990354</pub-id></citation>
      </ref>
      <ref id="CR209">
        <label>209.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takigami</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Guckelberger</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival</article-title>
          <source>Transplantation</source>
          <year>2000</year>
          <volume>70</volume>
          <fpage>864</fpage>
          <lpage>870</lpage>
        </citation>
        <citation citation-type="display-unstructured">Imai M, Takigami K, Guckelberger O et al (2000) Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 70:864&#x2013;870 <pub-id pub-id-type="pmid">11014639</pub-id></citation>
      </ref>
      <ref id="CR210">
        <label>210.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mizumoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kumamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>358</fpage>
          <lpage>365</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mizumoto N, Kumamoto T, Robson SC et al (2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8:358&#x2013;365 <pub-id pub-id-type="pmid">11927941</pub-id></citation>
      </ref>
      <ref id="CR211">
        <label>211.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>The control of production and release of haemostatic factors in the endothelial cell</article-title>
          <source>Baillieres Clin Haematol</source>
          <year>1993</year>
          <volume>6</volume>
          <fpage>629</fpage>
          <lpage>651</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pearson JD (1993) The control of production and release of haemostatic factors in the endothelial cell. Baillieres Clin Haematol 6:629&#x2013;651 <pub-id pub-id-type="pmid">8025346</pub-id></citation>
      </ref>
      <ref id="CR212">
        <label>212.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouchie</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Carney</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>866</fpage>
          <lpage>873</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bouchie JL, Chen HC, Carney R et al (2000) P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:866&#x2013;873 <pub-id pub-id-type="pmid">10712415</pub-id></citation>
      </ref>
      <ref id="CR213">
        <label>213.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>CAPRIE Steering Committee</collab>
          </person-group>
          <article-title>A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events</article-title>
          <source>Lancet</source>
          <year>1996</year>
          <volume>348</volume>
          <fpage>1329</fpage>
          <lpage>1339</lpage>
        </citation>
        <citation citation-type="display-unstructured">CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348:1329&#x2013;1339 <pub-id pub-id-type="pmid">8918275</pub-id></citation>
      </ref>
      <ref id="CR214">
        <label>214.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehta</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Yusuf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study</article-title>
          <source>Lancet</source>
          <year>2001</year>
          <volume>358</volume>
          <fpage>527</fpage>
          <lpage>533</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527&#x2013;533 <pub-id pub-id-type="pmid">11520521</pub-id></citation>
      </ref>
      <ref id="CR215">
        <label>215.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Payne</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>PD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>109</volume>
          <fpage>1476</fpage>
          <lpage>1481</lpage>
        </citation>
        <citation citation-type="display-unstructured">Payne DA, Jones CI, Hayes PD et al (2004) Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109:1476&#x2013;1481 <pub-id pub-id-type="pmid">15007001</pub-id></citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>An erratum to this article can be found at 
						<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11302-007-9092-9">http://dx.doi.org/10.1007/s11302-007-9092-9</ext-link></p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>